Trust the :@0.098953:0.076503:0.253506:0.076503:0.253506:0.033991:0.098953:0.033991:0.017379:0.013170:0.020728:0.018193:0.011495:0.010635:0.011495:0.020728:0.019868:0.010862
science behind:@0.253280:0.076949:0.520932:0.076949:0.520932:0.032913:0.253280:0.032913:0.019868:0.020728:0.010635:0.020728:0.022402:0.020728:0.020728:0.010635:0.022402:0.020728:0.022402:0.010635:0.022402:0.022629
 the original etoricoxib…:@0.520706:0.076503:0.931552:0.076503:0.931552:0.033991:0.520706:0.033991:0.010635:0.011495:0.020728:0.019868:0.010635:0.019868:0.013170:0.009006:0.020728:0.009006:0.020728:0.019868:0.009006:0.010635:0.019868:0.011495:0.019868:0.013170:0.009006:0.019053:0.019868:0.018148:0.009006:0.020728:0.045257
Ex:@0.620182:0.406692:0.656124:0.406692:0.656124:0.372291:0.620182:0.372291:0.018319:0.017623
cellence:@0.656124:0.406692:0.782305:0.406692:0.782305:0.372291:0.656124:0.372291:0.017623:0.017623:0.009526:0.009526:0.017623:0.019015:0.017623:0.017623
 in Efficacy:@0.782302:0.406178:0.935358:0.406178:0.935358:0.373518:0.782302:0.373518:0.008972:0.007627:0.017309:0.008972:0.017309:0.011178:0.011178:0.007627:0.015926:0.016599:0.015179:0.015179
1,2,4-11:@0.938234:0.391136:0.979155:0.391136:0.979155:0.380075:0.938234:0.380075:0.006077:0.003039:0.006077:0.003039:0.006077:0.004457:0.006077:0.006077
1,2:@0.913101:0.053340:0.933528:0.053340:0.933528:0.038470:0.913101:0.038470:0.008171:0.004085:0.008171
…:@0.605834:0.174182:0.649928:0.174182:0.649928:0.131381:0.605834:0.131381:0.044095
to deliver:@0.649928:0.174182:0.812503:0.174182:0.812503:0.131381:0.649928:0.131381:0.012339:0.021222:0.011427:0.022134:0.021222:0.009699:0.009699:0.019398:0.021222:0.014212
fast and lasting:@0.650216:0.212756:0.920678:0.212756:0.920678:0.169955:0.650216:0.169955:0.012339:0.021222:0.019446:0.012339:0.011427:0.021222:0.022134:0.022134:0.011427:0.009699:0.021222:0.019446:0.012339:0.009699:0.022134:0.022230
pain relief:@0.729775:0.251778:0.920678:0.251778:0.920678:0.207443:0.729775:0.207443:0.023911:0.022999:0.011427:0.023911:0.011427:0.015893:0.022134:0.011427:0.011427:0.022134:0.014212
2,3,a:@0.922578:0.191875:0.951099:0.191875:0.951099:0.177180:0.922578:0.177180:0.007267:0.003633:0.007267:0.003633:0.006722
a:@0.109084:0.415690:0.112980:0.415690:0.112980:0.408025:0.109084:0.408025:0.003896
in acute pain:@0.114318:0.419282:0.172978:0.419282:0.172978:0.408509:0.114318:0.408509:0.002516:0.005709:0.002959:0.005475:0.005253:0.005709:0.003194:0.005475:0.002959:0.005709:0.005475:0.002516:0.005709
APPROVED FOR A BROAD RANGE OF INDICATIONS:@0.167030:0.473942:0.866264:0.473942:0.866264:0.442017:0.167030:0.442017:0.019582:0.018921:0.018921:0.020208:0.019582:0.018329:0.017634:0.020208:0.009286:0.016973:0.019582:0.020208:0.008000:0.019582:0.009286:0.020208:0.020208:0.019582:0.019582:0.020208:0.009286:0.020208:0.019582:0.020834:0.019582:0.017634:0.009286:0.019582:0.016973:0.009286:0.009286:0.020834:0.020208:0.009286:0.018921:0.017669:0.016312:0.009286:0.019582:0.020834:0.018677
IN PATIENTS ≥ 16 YEARS OF AGE:@0.368977:0.493275:0.654378:0.493275:0.654378:0.472609:0.368977:0.472609:0.004826:0.013152:0.005677:0.010503:0.010527:0.010952:0.004826:0.010952:0.013152:0.010952:0.011828:0.005677:0.011757:0.005677:0.011355:0.011355:0.004802:0.010929:0.010952:0.011828:0.012277:0.011828:0.005677:0.013152:0.010503:0.004802:0.011828:0.012703:0.010952
 2:@0.654376:0.485662:0.664306:0.485662:0.664306:0.473614:0.654376:0.473614:0.003310:0.006620
ACUTE:@0.309236:0.544550:0.385264:0.544550:0.385264:0.517363:0.309236:0.517363:0.016587:0.015518:0.016067:0.013408:0.014449
CHRONIC:@0.693768:0.544550:0.798636:0.544550:0.798636:0.517363:0.693768:0.517363:0.015518:0.016587:0.016587:0.016067:0.017136:0.007455:0.015518
b:@0.692836:0.755311:0.696898:0.755311:0.696898:0.747646:0.692836:0.747646:0.004062
Limited to a maximum of 8 days treatment.:@0.697722:0.759038:0.896517:0.759038:0.896517:0.748266:0.697722:0.748266:0.005463:0.002503:0.008891:0.002503:0.003182:0.005463:0.005697:0.003243:0.003182:0.005463:0.003243:0.005463:0.003243:0.008891:0.005463:0.004994:0.002503:0.008891:0.005697:0.008891:0.003243:0.005463:0.003182:0.003243:0.005907:0.003243:0.005697:0.005463:0.004994:0.005007:0.003243:0.003182:0.003638:0.005463:0.005586:0.003182:0.008891:0.005463:0.005697:0.003182:0.002959
Doses shown are the maximum recommended daily dose. Doses greater than those recommended for each indication have either not demonstrated additional efficacy or have not been :@0.097946:0.786931:0.937563:0.786931:0.937563:0.776158:0.097946:0.776158:0.006719:0.005366:0.004918:0.005366:0.004918:0.003456:0.004918:0.005595:0.005486:0.007831:0.005595:0.003456:0.005366:0.003577:0.005366:0.003456:0.003130:0.005595:0.005366:0.003456:0.008725:0.005366:0.004906:0.002465:0.008725:0.005595:0.008725:0.003456:0.003577:0.005366:0.005148:0.005366:0.008725:0.008725:0.005366:0.005595:0.005595:0.005366:0.005595:0.003456:0.005595:0.005366:0.002465:0.002465:0.004906:0.003456:0.005595:0.005366:0.004918:0.005366:0.002453:0.003456:0.006719:0.005366:0.004918:0.005366:0.004918:0.003456:0.005595:0.003577:0.005366:0.005486:0.003130:0.005366:0.003577:0.003456:0.003130:0.005595:0.005366:0.005595:0.003456:0.003130:0.005595:0.005366:0.004918:0.005366:0.003456:0.003577:0.005366:0.005148:0.005366:0.008725:0.008725:0.005366:0.005595:0.005595:0.005366:0.005595:0.003456:0.003130:0.005366:0.003577:0.003456:0.005366:0.005366:0.005148:0.005595:0.003456:0.002465:0.005595:0.005595:0.002465:0.005148:0.005486:0.003130:0.002465:0.005366:0.005595:0.003456:0.005595:0.005486:0.004906:0.005366:0.003456:0.005366:0.002465:0.003130:0.005595:0.005366:0.003577:0.003456:0.005595:0.005366:0.003130:0.003456:0.005595:0.005474:0.008725:0.005366:0.005595:0.004918:0.003130:0.003577:0.005486:0.003130:0.005366:0.005595:0.003456:0.005366:0.005595:0.005595:0.002465:0.003130:0.002465:0.005366:0.005595:0.005366:0.002465:0.003456:0.005366:0.003130:0.003130:0.002465:0.005148:0.005366:0.004906:0.004906:0.003456:0.005366:0.003577:0.003456:0.005595:0.005486:0.004906:0.005366:0.003456:0.005595:0.005366:0.003130:0.003468:0.005595:0.005366:0.005366:0.005595:0.002900
studied. As the cardiovascular risks of EXINEF may increase with dose and duration of exposure, the shortest duration possible and the lowest effective daily dose should be used.:@0.097946:0.797798:0.900367:0.797798:0.900367:0.787025:0.097946:0.787025:0.004918:0.003130:0.005595:0.005595:0.002465:0.005366:0.005595:0.002453:0.002743:0.006042:0.004918:0.003190:0.003130:0.005595:0.005366:0.003190:0.005148:0.005366:0.003577:0.005595:0.002465:0.005366:0.004906:0.005366:0.004918:0.005148:0.005595:0.002465:0.005366:0.003577:0.003190:0.003577:0.002465:0.004918:0.005366:0.004918:0.003190:0.005366:0.003130:0.003190:0.005595:0.005813:0.002465:0.006719:0.005595:0.005366:0.003190:0.008725:0.005366:0.004906:0.003190:0.002465:0.005595:0.005148:0.003577:0.005366:0.005366:0.004918:0.005366:0.003190:0.007831:0.002465:0.003130:0.005595:0.003190:0.005595:0.005366:0.004918:0.005366:0.003190:0.005366:0.005595:0.005595:0.003190:0.005595:0.005595:0.003577:0.005486:0.003130:0.002465:0.005366:0.005595:0.003190:0.005366:0.003130:0.003190:0.005366:0.004906:0.005595:0.005366:0.004918:0.005595:0.003577:0.005366:0.002453:0.003190:0.003130:0.005595:0.005366:0.003190:0.004918:0.005595:0.005366:0.003577:0.003130:0.005366:0.004918:0.003130:0.003190:0.005595:0.005595:0.003577:0.005486:0.003130:0.002465:0.005366:0.005595:0.003190:0.005595:0.005366:0.004918:0.004918:0.002465:0.005595:0.002465:0.005366:0.003178:0.005366:0.005595:0.005595:0.003190:0.003130:0.005595:0.005366:0.003190:0.002465:0.005486:0.007831:0.005366:0.004918:0.003130:0.003190:0.005366:0.003130:0.003130:0.005366:0.005148:0.003130:0.002465:0.004906:0.005366:0.003190:0.005595:0.005366:0.002465:0.002465:0.004906:0.003190:0.005595:0.005366:0.004918:0.005366:0.003190:0.004918:0.005595:0.005366:0.005595:0.002465:0.005595:0.003190:0.005595:0.005366:0.003190:0.005595:0.004918:0.005366:0.005595:0.002900
Moderate to Severe Acute:@0.176813:0.593961:0.386686:0.593961:0.386686:0.575123:0.176813:0.575123:0.015097:0.009793:0.010201:0.009446:0.006794:0.009813:0.006039:0.009446:0.005386:0.006039:0.009793:0.005386:0.010589:0.009446:0.009058:0.009446:0.006794:0.009446:0.005386:0.011343:0.009446:0.010201:0.006039:0.009446
Post-operative Dental Surgery Pain:@0.116146:0.612004:0.386688:0.612004:0.386688:0.593166:0.116146:0.593166:0.009608:0.009315:0.008610:0.005714:0.007162:0.009315:0.009706:0.008982:0.006438:0.009334:0.005714:0.004618:0.008610:0.008982:0.005088:0.011154:0.008982:0.009706:0.005714:0.009334:0.004618:0.005088:0.010078:0.009706:0.006438:0.009706:0.008982:0.006790:0.008610:0.005088:0.009608:0.009334:0.004618:0.009785
90 mg once daily:@0.252721:0.629856:0.386687:0.629856:0.386687:0.611670:0.252721:0.611670:0.009993:0.009993:0.005496:0.015031:0.009639:0.005496:0.009243:0.009639:0.008868:0.009243:0.005496:0.009639:0.009243:0.004247:0.004247:0.008452
Acute Pain:@0.298043:0.655452:0.386687:0.655452:0.386687:0.636613:0.298043:0.636613:0.011575:0.009639:0.010409:0.006162:0.009639:0.005496:0.010305:0.010014:0.004996:0.010409
90 or 120 mg once daily:@0.190725:0.673304:0.381066:0.673304:0.381066:0.655118:0.190725:0.655118:0.009993:0.009993:0.005496:0.009243:0.006162:0.005496:0.009993:0.009993:0.009993:0.005496:0.015031:0.009639:0.005496:0.009243:0.009639:0.008868:0.009243:0.005496:0.009639:0.009243:0.004247:0.004247:0.008452
b:@0.381064:0.666602:0.386683:0.666602:0.386683:0.655999:0.381064:0.655999:0.005619
Acute Gouty Arthritis:@0.213479:0.698894:0.386687:0.698894:0.386687:0.680055:0.213479:0.680055:0.011575:0.009639:0.010409:0.006162:0.009639:0.005496:0.011575:0.009993:0.010409:0.006162:0.009243:0.005496:0.011575:0.006932:0.006162:0.010409:0.006932:0.004996:0.006162:0.004996:0.009243
120 mg once daily:@0.237108:0.716747:0.381066:0.716747:0.381066:0.698560:0.237108:0.698560:0.009993:0.009993:0.009993:0.005496:0.015031:0.009639:0.005496:0.009243:0.009639:0.008868:0.009243:0.005496:0.009639:0.009243:0.004247:0.004247:0.008452
b:@0.381064:0.710047:0.386683:0.710047:0.386683:0.699444:0.381064:0.699444:0.005619
Primary Dysmenorrhoea:@0.185937:0.742339:0.386688:0.742339:0.386688:0.723500:0.185937:0.723500:0.010805:0.006932:0.004996:0.015780:0.010014:0.007307:0.009243:0.005496:0.011950:0.009243:0.009243:0.015780:0.009639:0.010409:0.009993:0.006932:0.006932:0.010409:0.009993:0.009639:0.010014
120 mg once daily:@0.237109:0.760192:0.381067:0.760192:0.381067:0.742005:0.237109:0.742005:0.009993:0.009993:0.009993:0.005496:0.015031:0.009639:0.005496:0.009243:0.009639:0.008868:0.009243:0.005496:0.009639:0.009243:0.004247:0.004247:0.008452
b:@0.381064:0.753492:0.386683:0.753492:0.386683:0.742889:0.381064:0.742889:0.005619
Osteoarthritis:@0.692836:0.593961:0.805296:0.593961:0.805296:0.575123:0.692836:0.575123:0.011575:0.009243:0.006162:0.009639:0.009993:0.010014:0.006932:0.006162:0.010409:0.006932:0.004996:0.006162:0.004996:0.009243
30 or 60 mg once daily:@0.692836:0.611814:0.873184:0.611814:0.873184:0.593628:0.692836:0.593628:0.009993:0.009993:0.005496:0.009243:0.006162:0.005496:0.009993:0.009993:0.005496:0.015031:0.009639:0.005496:0.009243:0.009639:0.008868:0.009243:0.005496:0.009639:0.009243:0.004247:0.004247:0.008452
Rheumatoid Arthritis:@0.692836:0.637409:0.865128:0.637409:0.865128:0.618571:0.692836:0.618571:0.011575:0.010409:0.009639:0.010409:0.015780:0.010014:0.006162:0.009993:0.004996:0.010409:0.005496:0.011575:0.006932:0.006162:0.010409:0.006932:0.004996:0.006162:0.004996:0.009243
90 mg once daily:@0.692836:0.655262:0.826801:0.655262:0.826801:0.637076:0.692836:0.637076:0.009993:0.009993:0.005496:0.015031:0.009639:0.005496:0.009243:0.009639:0.008868:0.009243:0.005496:0.009639:0.009243:0.004247:0.004247:0.008452
Ankylosing Spondylitis:@0.692836:0.712070:0.881678:0.712070:0.881678:0.693232:0.692836:0.693232:0.011575:0.010409:0.010409:0.009243:0.004996:0.009993:0.009243:0.004996:0.010409:0.010409:0.005496:0.010805:0.010409:0.009993:0.010409:0.010409:0.009243:0.004996:0.004996:0.006162:0.004996:0.009243
90 mg once daily:@0.692836:0.729923:0.826801:0.729923:0.826801:0.711736:0.692836:0.711736:0.009993:0.009993:0.005496:0.015031:0.009639:0.005496:0.009243:0.009639:0.008868:0.009243:0.005496:0.009639:0.009243:0.004247:0.004247:0.008452
 For the short-term treatment of::@0.123617:0.571560:0.376243:0.571560:0.376243:0.553373:0.123617:0.553373:0.005496:0.008827:0.009243:0.006162:0.005496:0.005392:0.009639:0.009243:0.005496:0.008473:0.009639:0.009243:0.006162:0.005392:0.007328:0.005392:0.009243:0.006162:0.015031:0.005496:0.005392:0.006162:0.009243:0.009451:0.005392:0.015031:0.009243:0.009639:0.005392:0.005496:0.009243:0.005392:0.004996
 2:@0.376233:0.564861:0.385263:0.564861:0.385263:0.554258:0.376233:0.554258:0.003204:0.005826
For the symptomatic relief of::@0.692836:0.571560:0.912115:0.571560:0.912115:0.553373:0.692836:0.553373:0.008501:0.008905:0.005917:0.005270:0.005170:0.009289:0.008905:0.005270:0.008158:0.008138:0.014519:0.009289:0.005170:0.008905:0.014519:0.009107:0.005170:0.004059:0.008542:0.005270:0.005917:0.008905:0.004059:0.004059:0.008905:0.005170:0.005270:0.008905:0.005170:0.004846
 2:@0.912048:0.564861:0.920771:0.564861:0.920771:0.554258:0.912048:0.554258:0.003073:0.005651
For the treatment of::@0.692836:0.689265:0.846406:0.689265:0.846406:0.671079:0.692836:0.671079:0.008501:0.008905:0.005917:0.005270:0.005170:0.009289:0.008905:0.005270:0.005170:0.005917:0.008905:0.009107:0.005170:0.014519:0.008905:0.009289:0.005170:0.005270:0.008905:0.005170:0.004846
 2:@0.846340:0.682566:0.855064:0.682566:0.855064:0.671963:0.846340:0.671963:0.003073:0.005651
SELECTED SAFETY INFORMATION: :@0.097946:0.849353:0.182983:0.849353:0.182983:0.842852:0.097946:0.842852:0.003347:0.003116:0.002886:0.003116:0.003347:0.002880:0.003116:0.003578:0.001371:0.003347:0.003465:0.002998:0.003116:0.002880:0.003241:0.001371:0.001620:0.003690:0.002998:0.003465:0.003578:0.004724:0.003123:0.002880:0.001620:0.003465:0.003690:0.001390:0.001620
CONTRAINDICATIONS::@0.182734:0.849320:0.236147:0.849320:0.236147:0.842911:0.182734:0.842911:0.003347:0.003465:0.003578:0.002992:0.003465:0.003465:0.001608:0.003578:0.003578:0.001608:0.003235:0.003123:0.002992:0.001608:0.003465:0.003578:0.003235:0.001496
 EXINEF is contraindicated in: patients with known hypersensitivity to any of the excipients of EXINEF; patients with active peptic ulceration or gastrointestinal (GI) bleeding; patients with severe hepatic dysfunction (Child-Pugh score > 9 or serum albumin < 25 g/l); patients with estimated creatinine clearance :@0.236147:0.849255:0.936146:0.849255:0.936146:0.843068:0.236147:0.843068:0.001265:0.002886:0.002998:0.001272:0.003465:0.002886:0.002767:0.001265:0.001272:0.002537:0.001265:0.002655:0.002767:0.002886:0.001614:0.001845:0.002767:0.001272:0.002886:0.002886:0.001272:0.002655:0.002830:0.001614:0.002767:0.002886:0.001265:0.001272:0.002886:0.001265:0.001265:0.002886:0.002830:0.001614:0.001272:0.002767:0.002886:0.001614:0.002537:0.001265:0.004039:0.001272:0.001614:0.002886:0.001265:0.002767:0.002886:0.002830:0.004039:0.002886:0.001265:0.002886:0.002530:0.002886:0.002767:0.001845:0.002537:0.002767:0.002886:0.002537:0.001272:0.001614:0.001272:0.002530:0.001272:0.001614:0.002530:0.001265:0.001614:0.002767:0.001265:0.002767:0.002948:0.002530:0.001265:0.002767:0.001614:0.001265:0.001614:0.002886:0.002767:0.001265:0.002767:0.002530:0.002655:0.001272:0.002886:0.001272:0.002767:0.002886:0.001614:0.002537:0.001265:0.002767:0.001614:0.001265:0.002886:0.002998:0.001272:0.003465:0.002886:0.002767:0.001496:0.001265:0.002886:0.002830:0.001614:0.001272:0.002767:0.002886:0.001614:0.002537:0.001265:0.004039:0.001272:0.001614:0.002886:0.001265:0.002767:0.002655:0.001614:0.001272:0.002530:0.002767:0.001265:0.002886:0.002767:0.002886:0.001614:0.001272:0.002655:0.001265:0.002886:0.001272:0.002655:0.002767:0.001845:0.002830:0.001614:0.001272:0.002767:0.002886:0.001265:0.002767:0.001845:0.001265:0.002886:0.002767:0.002537:0.001614:0.001845:0.002767:0.001272:0.002886:0.001614:0.002767:0.002537:0.001614:0.001272:0.002886:0.002767:0.001272:0.001265:0.001502:0.003347:0.001272:0.001502:0.001265:0.002886:0.001272:0.002767:0.002767:0.002886:0.001272:0.002886:0.002886:0.001496:0.001265:0.002886:0.002830:0.001614:0.001272:0.002767:0.002886:0.001614:0.002537:0.001265:0.004039:0.001272:0.001614:0.002886:0.001265:0.002537:0.002767:0.002530:0.002767:0.001845:0.002767:0.001265:0.002886:0.002767:0.002886:0.002830:0.001614:0.001272:0.002655:0.001265:0.002948:0.002530:0.002537:0.001614:0.002886:0.002886:0.002655:0.001614:0.001272:0.002767:0.002886:0.001265:0.001502:0.003235:0.002886:0.001272:0.001272:0.002886:0.002194:0.002998:0.002886:0.002886:0.002886:0.001265:0.002537:0.002655:0.002767:0.001845:0.002767:0.001265:0.003740:0.001265:0.002992:0.001265:0.002767:0.001845:0.001265:0.002537:0.002767:0.001845:0.002886:0.004500:0.001265:0.002767:0.001272:0.002886:0.002886:0.004500:0.001272:0.002886:0.001265:0.003740:0.001265:0.002992:0.002992:0.001265:0.002886:0.001733:0.001272:0.001502:0.001496:0.001265:0.002886:0.002830:0.001614:0.001272:0.002767:0.002886:0.001614:0.002537:0.001265:0.004039:0.001272:0.001614:0.002886:0.001265:0.002767:0.002537:0.001614:0.001272:0.004500:0.002830:0.001614:0.002767:0.002886:0.001265:0.002655:0.001845:0.002767:0.002830:0.001614:0.001272:0.002886:0.001272:0.002886:0.002767:0.001265:0.002530:0.001272:0.002767:0.002767:0.001845:0.002767:0.002886:0.002655:0.002767:0.001496
 ammatory drugs (NSAIDs) including EXINEF; hypertension which has not been adequately controlled; pregnancy and lactation; children and adolescents under 16 years of age; patients withﬂ< 30 ml/min; patients who have developed signs of asthma, acute rhinitis, nasal polyps, angioedema or urticaria following the administration of aspirin or other non-steroidal anti-in :@0.097946:0.855610:0.936177:0.855610:0.936177:0.849423:0.097946:0.849423:0.002886:0.001614:0.001272:0.004039:0.001215:0.002537:0.001614:0.002886:0.002767:0.001272:0.001614:0.002830:0.002886:0.001215:0.001496:0.002767:0.002886:0.002830:0.001215:0.001614:0.002767:0.001215:0.002537:0.001845:0.002767:0.002767:0.002530:0.001215:0.002992:0.002992:0.001215:0.001845:0.002767:0.002886:0.002886:0.002886:0.001215:0.002537:0.001614:0.002886:0.002767:0.002655:0.002537:0.002767:0.001272:0.002767:0.002886:0.002767:0.001215:0.002886:0.002886:0.002767:0.001215:0.002886:0.002767:0.001845:0.002886:0.001272:0.001272:0.002886:0.002655:0.001215:0.001496:0.002886:0.002767:0.001272:0.001614:0.002830:0.001614:0.002655:0.002767:0.001272:0.001215:0.002886:0.002886:0.002767:0.001215:0.002530:0.002530:0.002886:0.002767:0.002886:0.002886:0.002767:0.001845:0.002886:0.001215:0.001496:0.002886:0.002767:0.001272:0.001272:0.002767:0.001845:0.001614:0.002886:0.002767:0.002655:0.001215:0.002530:0.001272:0.002767:0.001614:0.002830:0.002886:0.002886:0.002767:0.002886:0.002767:0.001215:0.002886:0.002767:0.002767:0.002886:0.001215:0.001614:0.002767:0.002886:0.001215:0.002537:0.002767:0.002886:0.001215:0.002886:0.002655:0.001272:0.002886:0.004039:0.001215:0.002886:0.002767:0.001272:0.002537:0.002886:0.002767:0.001614:0.001845:0.002767:0.002886:0.002530:0.002886:0.001215:0.001496:0.002767:0.002886:0.003465:0.001272:0.002998:0.002886:0.001215:0.002886:0.002886:0.001272:0.002886:0.002886:0.001272:0.002530:0.002886:0.001272:0.001215:0.001502:0.002537:0.003465:0.001272:0.003116:0.003116:0.003465:0.001502:0.001215:0.002537:0.002886:0.002886:0.001845:0.002886:0.001215:0.002530:0.001957:0.002767:0.001614:0.002830:0.004500:0.004500:0.002767:0.001440:0.001440:0.002886:0.001272:0.002194:0.001272:0.001614:0.002886:0.002767:0.001215:0.001272:0.002767:0.002886:0.001272:0.002767:0.001845:0.002767:0.001614:0.002537:0.002194:0.002886:0.002767:0.002886:0.001215:0.001845:0.002767:0.002886:0.001614:0.002767:0.001215:0.001845:0.002767:0.001215:0.002886:0.001272:0.001845:0.001272:0.002886:0.002537:0.002767:0.001215:0.001614:0.002767:0.001215:0.002886:0.002767:0.001272:0.001614:0.002830:0.001845:0.001614:0.002537:0.001272:0.002886:0.001272:0.004500:0.002886:0.002761:0.001215:0.002767:0.002886:0.001614:0.001215:0.002886:0.002886:0.001272:0.004039:0.002830:0.001272:0.001272:0.002767:0.001614:0.001215:0.002767:0.001272:0.001845:0.002767:0.002655:0.001272:0.001614:0.001845:0.002886:0.001215:0.001845:0.002767:0.001215:0.002767:0.004500:0.002767:0.002886:0.002767:0.002767:0.001272:0.002886:0.002886:0.002767:0.001215:0.001265:0.002537:0.002886:0.002530:0.001272:0.002767:0.002886:0.001215:0.001272:0.002767:0.002537:0.002767:0.002886:0.001215:0.001265:0.002537:0.001272:0.001614:0.001272:0.002886:0.001272:0.002886:0.001845:0.001215:0.002767:0.001614:0.002886:0.002655:0.002767:0.001215:0.001265:0.002767:0.004500:0.002886:0.001614:0.002537:0.002767:0.001215:0.001614:0.002767:0.001215:0.002537:0.002886:0.002886:0.001272:0.002537:0.001215:0.002886:0.002767:0.002886:0.002767:0.001272:0.002767:0.002530:0.002767:0.002886:0.001215:0.002767:0.002530:0.002830:0.002886:0.001215:0.002767:0.002886:0.004039:0.001215:0.002537:0.001614:0.002886:0.002767:0.001272:0.001614:0.002830:0.002886:0.001215:0.001496:0.002886:0.001272:0.004500:0.001733:0.001272:0.004500:0.001215:0.002992:0.002992:0.001215:0.003740:0.001496
 ammatory bowel disease; patients with congestive heart failure (NYHA II - IV); established ischaemic heart disease, peripheral arterial disease and/or cerebrovascular disease; perioperative analgesia in the setting of coronary artery bypass surgery (CABG).ﬂin :@0.097946:0.861965:0.686264:0.861965:0.686264:0.855778:0.097946:0.855778:0.001265:0.001502:0.003347:0.003235:0.003116:0.003235:0.001458:0.001334:0.002530:0.001957:0.002767:0.002886:0.001845:0.002886:0.002537:0.001334:0.002537:0.002537:0.002767:0.002886:0.002530:0.002886:0.001334:0.002530:0.001957:0.002767:0.001614:0.001845:0.002767:0.001334:0.002530:0.001957:0.002767:0.002886:0.002767:0.001845:0.002767:0.002655:0.001334:0.001614:0.002767:0.001334:0.002886:0.002886:0.001272:0.001614:0.001614:0.002767:0.002537:0.001334:0.002767:0.002886:0.001614:0.001334:0.002886:0.001272:0.001334:0.002767:0.001272:0.002537:0.002767:0.002886:0.001272:0.002767:0.002886:0.002767:0.001334:0.002767:0.002530:0.001272:0.001614:0.002830:0.001845:0.002767:0.002886:0.002767:0.001272:0.001845:0.002767:0.002886:0.001334:0.001496:0.002767:0.002537:0.002767:0.002767:0.002537:0.001272:0.002886:0.001334:0.001845:0.002767:0.001272:0.002886:0.002655:0.002537:0.002767:0.002530:0.002767:0.001845:0.002886:0.002767:0.001845:0.002767:0.002655:0.001334:0.001845:0.002767:0.001733:0.002886:0.002886:0.002767:0.001334:0.002767:0.002537:0.002767:0.002767:0.002537:0.001272:0.002886:0.001334:0.001272:0.002767:0.001272:0.001845:0.002767:0.001614:0.001845:0.002767:0.001334:0.001272:0.002767:0.001845:0.002730:0.002886:0.002886:0.001272:0.001845:0.002767:0.002886:0.001334:0.001265:0.002767:0.002537:0.002767:0.002767:0.002537:0.001272:0.002886:0.001334:0.001614:0.001845:0.002767:0.002767:0.002886:0.001334:0.002655:0.001272:0.004500:0.002767:0.002767:0.002886:0.002655:0.002537:0.001272:0.001334:0.002886:0.002767:0.002886:0.002537:0.001272:0.001272:0.002886:0.002767:0.001614:0.002537:0.002767:0.001334:0.001496:0.001502:0.002880:0.001272:0.001334:0.002194:0.001334:0.001272:0.001272:0.001334:0.003116:0.003347:0.002880:0.003465:0.001502:0.001334:0.002767:0.001845:0.002886:0.001272:0.001272:0.002767:0.001614:0.001334:0.001614:0.001845:0.002767:0.002767:0.002886:0.001334:0.002767:0.002530:0.001272:0.001614:0.002537:0.002767:0.002886:0.002886:0.002767:0.002655:0.001334:0.002886:0.001614:0.001272:0.004039:0.001334:0.002537:0.001614:0.002886:0.002767:0.001272:0.001614:0.002830:0.002886:0.001334:0.001496:0.002767:0.002537:0.002767:0.002767:0.002537:0.001272:0.002886:0.001334:0.001272:0.002767:0.004039:0.002830:0.002886:0.001334:0.002530:0.001957:0.002767:0.001614:0.002830:0.004500:0.004500:0.002767:0.001440:0.001440:0.002886:0.001272:0.001496
WARNINGS AND SPECIAL PRECAUTIONS: :@0.686101:0.862030:0.786134:0.862030:0.786134:0.855621:0.686101:0.855621:0.004625:0.003465:0.003465:0.003578:0.001608:0.003578:0.003465:0.003235:0.001334:0.003465:0.003578:0.003578:0.001334:0.003235:0.003235:0.002998:0.003347:0.001608:0.003465:0.002886:0.001334:0.003235:0.003465:0.002998:0.003235:0.003465:0.003353:0.002992:0.001608:0.003465:0.003578:0.003235:0.001496:0.001496
EXINEF may predispose to cardiovascular events, gastrointestinal :@0.785966:0.861965:0.936183:0.861965:0.936183:0.855778:0.785966:0.855778:0.002886:0.002998:0.001272:0.003465:0.002886:0.002767:0.001334:0.004500:0.002767:0.002530:0.001334:0.002886:0.001845:0.002767:0.002886:0.001272:0.002537:0.002886:0.002767:0.002537:0.002767:0.001334:0.001614:0.002767:0.001334:0.002655:0.002767:0.001845:0.002886:0.001272:0.002767:0.002530:0.002767:0.002537:0.002655:0.002886:0.001272:0.002767:0.001845:0.001334:0.002767:0.002530:0.002767:0.002886:0.001614:0.002537:0.001265:0.001334:0.002886:0.002767:0.002537:0.001614:0.001845:0.002767:0.001272:0.002886:0.001614:0.002767:0.002537:0.001614:0.001272:0.002886:0.002767:0.001272:0.001496
 ow and thereby impair renal function. Cautionﬂevents or cutaneous reactions which may be fatal. Long-term administration of NSAIDs such as EXINEF has resulted in renal papillary necrosis and other renal injury. Under conditions of compromised renal perfusion, administration of EXINEF may cause a reduction in prostaglandin formation and, secondarily, in renal blood  :@0.097946:0.868320:0.936152:0.868320:0.936152:0.862133:0.097946:0.862133:0.002886:0.002767:0.001272:0.001614:0.002886:0.002767:0.003235:0.001215:0.001265:0.002886:0.002767:0.001272:0.001614:0.002655:0.002886:0.002886:0.001614:0.001215:0.001272:0.002767:0.002886:0.002767:0.001845:0.001215:0.001845:0.001272:0.002767:0.002886:0.004500:0.001272:0.001215:0.002530:0.002886:0.002767:0.001845:0.002767:0.002886:0.001614:0.001215:0.002886:0.002886:0.002767:0.001215:0.004039:0.002830:0.001440:0.001440:0.001215:0.002886:0.002767:0.002767:0.001272:0.002886:0.001215:0.001272:0.002767:0.002886:0.002767:0.001845:0.001215:0.002886:0.001272:0.001215:0.001265:0.002188:0.001272:0.001272:0.001845:0.002767:0.002886:0.002886:0.002767:0.002655:0.002767:0.002537:0.001215:0.001265:0.002886:0.002886:0.002767:0.001215:0.002886:0.002767:0.001272:0.001614:0.002830:0.004500:0.001845:0.002767:0.001614:0.001215:0.002886:0.001272:0.002886:0.002886:0.002767:0.001272:0.002886:0.002830:0.001614:0.002537:0.002767:0.001845:0.002886:0.001215:0.002886:0.001272:0.001215:0.002886:0.002767:0.001272:0.001614:0.002655:0.002886:0.002892:0.002767:0.001845:0.001215:0.002767:0.001215:0.002767:0.002537:0.002886:0.002767:0.002655:0.001215:0.002530:0.002767:0.004500:0.001215:0.002767:0.002886:0.003465:0.001272:0.002998:0.002886:0.001215:0.001614:0.002767:0.001215:0.002886:0.002767:0.001272:0.001614:0.002830:0.001845:0.001614:0.002537:0.001272:0.002886:0.001272:0.004500:0.002886:0.002767:0.001215:0.001265:0.002886:0.002767:0.001272:0.002537:0.002886:0.001614:0.001845:0.002767:0.002886:0.001215:0.001272:0.002767:0.002886:0.002767:0.001845:0.001215:0.002886:0.002767:0.002537:0.001272:0.004500:0.002767:0.001845:0.002886:0.004500:0.002767:0.002655:0.001215:0.001614:0.002767:0.001215:0.002537:0.002886:0.002767:0.001272:0.001614:0.001272:0.002886:0.002886:0.002767:0.002655:0.001215:0.001845:0.002767:0.002886:0.002886:0.003235:0.001215:0.001265:0.002188:0.001957:0.002886:0.001272:0.002886:0.001272:0.001215:0.001272:0.002767:0.002886:0.002767:0.001845:0.001215:0.001845:0.002767:0.002886:0.001614:0.002767:0.001215:0.002886:0.002886:0.002767:0.001215:0.002537:0.001272:0.002537:0.002767:0.001845:0.002655:0.002767:0.002886:0.001215:0.002530:0.001957:0.002767:0.001272:0.001278:0.001272:0.002886:0.002830:0.002886:0.001215:0.001272:0.002767:0.002886:0.002767:0.001845:0.001215:0.002886:0.001272:0.001215:0.002886:0.002767:0.001614:0.001272:0.002886:0.002537:0.002767:0.001845:0.001215:0.002537:0.002767:0.002886:0.001215:0.002767:0.002886:0.003465:0.001272:0.002998:0.002886:0.001215:0.002537:0.002767:0.001215:0.002886:0.002655:0.002886:0.002537:0.001215:0.002537:0.003465:0.001272:0.003116:0.003116:0.003465:0.001215:0.001614:0.002767:0.001215:0.002886:0.002767:0.001272:0.001614:0.002830:0.001845:0.001614:0.002537:0.001272:0.002886:0.001272:0.004500:0.002886:0.002767:0.001215:0.004500:0.001845:0.002767:0.001614:0.002194:0.002886:0.002886:0.002767:0.002767:0.001215:0.001265:0.001272:0.002767:0.001614:0.002830:0.001614:0.001215:0.002767:0.002886:0.001215:0.002530:0.002767:0.004500:0.001215:0.002886:0.002655:0.001272:0.002886:0.004039:0.001215:0.002537:0.002886:0.002767:0.001272:0.001614:0.002655:0.002767:0.002767:0.001845:0.001215:0.002537:0.002886:0.002767:0.002767:0.002886:0.002767:0.001614:0.002886:0.002655:0.001215:0.001845:0.002767:0.001215:0.002537:0.001614:0.002886:0.002767:0.002530:0.002767:0.001496
should be used when initiating treatment with EXINEF in patients with dehydration. Fluid retention, oedema and hypertension have been observed in patients taking EXINEF. All NSAIDs, including EXINEF, can be associated with new onset or recurrent congestive cardiac failure. Special attention should be paid to blood pressure monitoring during treatment with EXINEF. :@0.097946:0.874675:0.936183:0.874675:0.936183:0.868488:0.097946:0.868488:0.002537:0.002886:0.002767:0.002886:0.001272:0.002886:0.001346:0.002886:0.002767:0.001346:0.002886:0.002537:0.002767:0.002886:0.001346:0.004039:0.002886:0.002767:0.002886:0.001346:0.001272:0.002886:0.001272:0.001614:0.001272:0.002830:0.001614:0.001272:0.002886:0.002886:0.001346:0.001614:0.001845:0.002767:0.002830:0.001614:0.004500:0.002767:0.002886:0.001614:0.001346:0.004039:0.001272:0.001614:0.002886:0.001346:0.002886:0.002998:0.001272:0.003465:0.002886:0.002767:0.001346:0.001272:0.002886:0.001346:0.002886:0.002830:0.001614:0.001272:0.002767:0.002886:0.001614:0.002537:0.001346:0.004039:0.001272:0.001614:0.002886:0.001346:0.002886:0.002767:0.002886:0.002530:0.002886:0.001845:0.002830:0.001614:0.001272:0.002767:0.002886:0.001265:0.001346:0.002767:0.001272:0.002886:0.001272:0.002886:0.001346:0.001845:0.002767:0.001614:0.002767:0.002886:0.001614:0.001272:0.002767:0.002886:0.001265:0.001346:0.002767:0.002767:0.002886:0.002767:0.004500:0.002767:0.001346:0.002767:0.002886:0.002886:0.001346:0.002886:0.002530:0.002886:0.002767:0.001845:0.001614:0.002767:0.002886:0.002537:0.001272:0.002767:0.002886:0.001346:0.002886:0.002830:0.002512:0.002767:0.001346:0.002886:0.002767:0.002767:0.002886:0.001346:0.002767:0.002886:0.002537:0.002767:0.001957:0.002530:0.002767:0.002886:0.001346:0.001272:0.002886:0.001346:0.002886:0.002830:0.001614:0.001272:0.002767:0.002886:0.001614:0.002537:0.001346:0.001614:0.002767:0.002767:0.001272:0.002886:0.002886:0.001346:0.002886:0.002998:0.001272:0.003465:0.002886:0.002076:0.001265:0.001116:0.003116:0.001272:0.001272:0.001346:0.003465:0.003116:0.003116:0.001272:0.003465:0.002537:0.001265:0.001346:0.001272:0.002886:0.002530:0.001272:0.002886:0.002886:0.001272:0.002886:0.002886:0.001346:0.002886:0.002998:0.001272:0.003465:0.002886:0.002076:0.001265:0.001346:0.002655:0.002767:0.002886:0.001346:0.002886:0.002767:0.001346:0.002767:0.002537:0.002537:0.002767:0.002655:0.001272:0.002830:0.001614:0.002767:0.002886:0.001346:0.004039:0.001272:0.001614:0.002886:0.001346:0.002886:0.002767:0.004039:0.001346:0.002767:0.002886:0.002537:0.002767:0.001614:0.001346:0.002767:0.001845:0.001346:0.001845:0.002767:0.002655:0.002886:0.001845:0.001845:0.002767:0.002886:0.001614:0.001346:0.002655:0.002767:0.002886:0.002886:0.002767:0.002537:0.001614:0.001253:0.002530:0.002767:0.001346:0.002655:0.002767:0.001845:0.002886:0.001272:0.002767:0.002655:0.001346:0.001614:0.002767:0.001272:0.001272:0.002886:0.001845:0.002767:0.001265:0.001346:0.003116:0.002886:0.002767:0.002655:0.001272:0.002767:0.001272:0.001346:0.002830:0.001614:0.001614:0.002767:0.002886:0.001614:0.001272:0.002767:0.002886:0.001346:0.002537:0.002886:0.002767:0.002886:0.001272:0.002886:0.001346:0.002886:0.002767:0.001346:0.002886:0.002767:0.001272:0.002886:0.001346:0.001614:0.002767:0.001346:0.002886:0.001272:0.002767:0.002767:0.002886:0.001346:0.002886:0.001845:0.002767:0.002537:0.002537:0.002886:0.001845:0.002767:0.001346:0.004500:0.002767:0.002886:0.001272:0.001614:0.002767:0.001845:0.001272:0.002886:0.002886:0.001346:0.002886:0.002886:0.001845:0.001272:0.002886:0.002886:0.001346:0.001614:0.001845:0.002767:0.002830:0.001614:0.004500:0.002767:0.002886:0.001614:0.001346:0.004039:0.001272:0.001614:0.002886:0.001346:0.002886:0.002998:0.001272:0.003465:0.002886:0.002076:0.001265:0.001496
Clinical trials suggest that the selective COX-2 inhibitor class of medicines such as EXINEF are associated with an increased risk of thrombotic events (especially myocardial infarction (MI) and stroke). As the cardiovascular risks of selective COX-2 inhibitors may increase with dose and duration of exposure, the shortest duration possible and the lowest effective daily :@0.097946:0.881030:0.936140:0.881030:0.936140:0.874843:0.097946:0.874843:0.003235:0.001272:0.001272:0.002886:0.001272:0.002655:0.002767:0.001272:0.001396:0.001614:0.001845:0.001272:0.002767:0.001272:0.002537:0.001396:0.002537:0.002886:0.002886:0.002886:0.002767:0.002537:0.001614:0.001396:0.001614:0.002886:0.002830:0.001614:0.001396:0.001614:0.002886:0.002767:0.001396:0.002537:0.002767:0.001272:0.002767:0.002655:0.001614:0.001272:0.002530:0.002767:0.001396:0.003235:0.003316:0.002998:0.002194:0.002992:0.001396:0.001272:0.002886:0.002886:0.001272:0.002886:0.001272:0.001614:0.002767:0.001845:0.001396:0.002530:0.001272:0.002767:0.002537:0.002537:0.001396:0.002767:0.001614:0.001396:0.004500:0.002767:0.002886:0.001272:0.002655:0.001272:0.002886:0.002767:0.002537:0.001396:0.002537:0.002886:0.002655:0.002886:0.001396:0.002767:0.002537:0.001396:0.002886:0.002998:0.001272:0.003465:0.002886:0.002767:0.001396:0.002767:0.001845:0.002767:0.001396:0.002767:0.002537:0.002537:0.002767:0.002655:0.001272:0.002830:0.001614:0.002767:0.002886:0.001396:0.004039:0.001272:0.001614:0.002886:0.001396:0.002767:0.002886:0.001396:0.001272:0.002886:0.002655:0.001845:0.002767:0.002767:0.002537:0.002767:0.002886:0.001396:0.001845:0.001272:0.002537:0.002767:0.001396:0.002767:0.001614:0.001396:0.001614:0.002886:0.001845:0.002767:0.004500:0.002886:0.002767:0.001614:0.001272:0.002655:0.001396:0.002767:0.002530:0.002767:0.002886:0.001614:0.002537:0.001396:0.001502:0.002767:0.002537:0.002886:0.002767:0.002655:0.001272:0.002767:0.001272:0.001272:0.002530:0.001396:0.004500:0.002530:0.002767:0.002655:0.002767:0.001845:0.002886:0.001272:0.002767:0.001272:0.001396:0.001272:0.002886:0.001614:0.002767:0.001845:0.002655:0.001614:0.001272:0.002767:0.002886:0.001396:0.001502:0.004388:0.001272:0.001502:0.001396:0.002767:0.002886:0.002886:0.001396:0.002537:0.001614:0.001845:0.002767:0.002767:0.002767:0.001502:0.001265:0.001166:0.003116:0.002537:0.001396:0.001614:0.002886:0.002767:0.001396:0.002655:0.002767:0.001845:0.002886:0.001272:0.002767:0.002530:0.002767:0.002537:0.002655:0.002886:0.001272:0.002767:0.001845:0.001396:0.001845:0.001272:0.002537:0.002767:0.002537:0.001396:0.002767:0.001614:0.001396:0.002537:0.002767:0.001272:0.002767:0.002655:0.001614:0.001272:0.002530:0.002767:0.001396:0.003235:0.003316:0.002998:0.002194:0.002992:0.001396:0.001272:0.002886:0.002948:0.001272:0.002886:0.001272:0.001614:0.002767:0.001845:0.002537:0.001396:0.004500:0.002767:0.002530:0.001396:0.001272:0.002886:0.002655:0.001845:0.002767:0.002767:0.002537:0.002767:0.001396:0.004039:0.001272:0.001614:0.002886:0.001396:0.002886:0.002767:0.002537:0.002767:0.001396:0.002767:0.002886:0.002886:0.001396:0.002886:0.002886:0.001845:0.002830:0.001614:0.001272:0.002767:0.002886:0.001396:0.002767:0.001614:0.001396:0.002767:0.002530:0.002886:0.002767:0.002537:0.002886:0.001845:0.002767:0.001265:0.001396:0.001614:0.002886:0.002767:0.001396:0.002537:0.002886:0.002767:0.001845:0.001614:0.002767:0.002537:0.001614:0.001396:0.002886:0.002886:0.001845:0.002830:0.001614:0.001272:0.002767:0.002886:0.001396:0.002886:0.002767:0.002537:0.002537:0.001272:0.002886:0.001272:0.002767:0.001396:0.002767:0.002886:0.002886:0.001396:0.001614:0.002886:0.002767:0.001396:0.001272:0.002830:0.004039:0.002767:0.002537:0.001614:0.001396:0.002767:0.001614:0.001614:0.002767:0.002655:0.001614:0.001272:0.002530:0.002767:0.001396:0.002886:0.002767:0.001272:0.001272:0.002530:0.001496
 cant risk factors for cardiovascular events (e.g. hypertension, hyperlipidaemia, diabetes mellitus, smoking) should only be treated with EXINEF after careful consideration.ﬁdose should be used. Patients with signi :@0.097946:0.887385:0.578079:0.887385:0.578079:0.881198:0.097946:0.881198:0.001265:0.002886:0.002767:0.001272:0.001614:0.002830:0.001845:0.002767:0.002886:0.001272:0.002537:0.002886:0.002767:0.002655:0.001290:0.001272:0.002886:0.001614:0.002767:0.001845:0.002767:0.002655:0.001290:0.001845:0.002767:0.001614:0.001614:0.002767:0.001290:0.002767:0.002886:0.003465:0.001272:0.002998:0.002886:0.001290:0.002886:0.001614:0.001272:0.004039:0.001290:0.002886:0.002767:0.001614:0.002830:0.002767:0.001845:0.001614:0.001290:0.002767:0.002886:0.001290:0.002530:0.001272:0.002886:0.002767:0.001290:0.002886:0.001272:0.002886:0.002767:0.002886:0.002537:0.001290:0.001502:0.002886:0.002886:0.001272:0.002767:0.002767:0.004500:0.002537:0.001290:0.001265:0.002537:0.002886:0.001614:0.001272:0.001272:0.001272:0.002767:0.004500:0.001290:0.002537:0.002767:0.001614:0.002767:0.002867:0.002767:0.001272:0.002886:0.001290:0.001265:0.002767:0.001272:0.004500:0.002767:0.002767:0.002886:0.001272:0.002886:0.001272:0.001272:0.001845:0.002767:0.002886:0.002530:0.002886:0.001290:0.001265:0.002886:0.002767:0.001272:0.002537:0.002886:0.002767:0.001614:0.001845:0.002767:0.002886:0.002530:0.002886:0.001290:0.001265:0.002886:0.001496:0.002767:0.001502:0.001290:0.002537:0.001614:0.002886:0.002767:0.002530:0.002767:0.001290:0.001845:0.002767:0.001272:0.002886:0.002655:0.002537:0.002767:0.002530:0.002767:0.001272:0.002886:0.001845:0.002767:0.002655:0.001290:0.001845:0.002767:0.001614:0.001290:0.002537:0.001845:0.002767:0.001614:0.002655:0.002767:0.001614:0.001290:0.002767:0.002537:0.001272:0.001845:0.001290:0.001614:0.002886:0.002767:0.002655:0.001440:0.001440:0.001272:0.002886:0.002886:0.001272:0.002537:0.001290:0.002886:0.001614:0.001272:0.004039:0.001290:0.002537:0.001614:0.002886:0.002767:0.001272:0.001614:0.002830:0.002886:0.001290:0.001265:0.002886:0.002767:0.002537:0.002886:0.001290:0.002767:0.002886:0.001290:0.002886:0.001272:0.002886:0.002767:0.002886:0.002537:0.001290:0.002767:0.002537:0.002767:0.002886:0.001496
EXINEF is not a substitute for aspirin for cardiovascular prophylaxis because of its lack of effect on platelets:@0.577873:0.887450:0.842134:0.887450:0.842134:0.881041:0.577873:0.881041:0.002998:0.003347:0.001608:0.003578:0.002998:0.002886:0.001290:0.001496:0.002767:0.001290:0.003116:0.002992:0.001845:0.001290:0.002998:0.001290:0.002767:0.003116:0.003116:0.002767:0.001845:0.001496:0.001845:0.003116:0.001845:0.002886:0.001290:0.001845:0.002992:0.002076:0.001290:0.002998:0.002767:0.003116:0.001496:0.002076:0.001496:0.003116:0.001290:0.001845:0.002992:0.002076:0.001290:0.002886:0.002998:0.002076:0.003116:0.001496:0.003054:0.002668:0.002998:0.002767:0.002886:0.003116:0.001496:0.002998:0.002076:0.001290:0.003116:0.002076:0.002992:0.003116:0.003116:0.002767:0.001496:0.002998:0.002880:0.001496:0.002767:0.001290:0.003116:0.002886:0.002886:0.002998:0.003116:0.002767:0.002886:0.001290:0.002992:0.001845:0.001290:0.001496:0.001845:0.002767:0.001290:0.001496:0.002998:0.002886:0.003116:0.001290:0.002992:0.001845:0.001290:0.002886:0.001845:0.001845:0.002886:0.002886:0.001845:0.001290:0.002992:0.003116:0.001290:0.003116:0.001496:0.002998:0.001845:0.002886:0.001496:0.002886:0.001845:0.002767
. When using EXINEF in the elderly and in :@0.842090:0.887385:0.936177:0.887385:0.936177:0.881198:0.842090:0.881198:0.001265:0.001060:0.004500:0.002886:0.002767:0.002886:0.001290:0.002886:0.002537:0.001272:0.002886:0.002886:0.001290:0.002886:0.002998:0.001272:0.003465:0.002886:0.002767:0.001290:0.001272:0.002886:0.001290:0.001614:0.002886:0.002767:0.001290:0.002767:0.001272:0.002886:0.002767:0.001845:0.001272:0.002530:0.001290:0.002767:0.002886:0.002886:0.001290:0.001272:0.002886:0.001496
 ed. If these patients deteriorate during treatment, appropriate measures should be taken, including discontinuation of EXINEF. Upper GI complications, some of them resulting in fatal outcome, have occurred in patients treated with EXINEF. There is an increase in theﬁpatients with renal, hepatic or cardiac dysfunction, medically appropriate supervision should be intensi :@0.097946:0.893740:0.936214:0.893740:0.936214:0.887553:0.097946:0.887553:0.002767:0.002886:0.001614:0.001303:0.002886:0.001272:0.001303:0.002767:0.002537:0.002767:0.002767:0.001845:0.002655:0.002886:0.001272:0.001303:0.002886:0.002767:0.001303:0.002537:0.001272:0.001303:0.002767:0.001845:0.002767:0.002886:0.002886:0.001066:0.001265:0.002076:0.002886:0.003465:0.001272:0.002998:0.002886:0.001303:0.002886:0.001614:0.001272:0.004039:0.001303:0.002886:0.002767:0.001614:0.002830:0.002767:0.001845:0.001614:0.001303:0.002537:0.001614:0.002886:0.002767:0.001272:0.001614:0.002830:0.002886:0.001303:0.002886:0.001272:0.001303:0.002886:0.002767:0.001845:0.001845:0.002886:0.002655:0.002655:0.002767:0.001303:0.002767:0.002530:0.002830:0.002886:0.001303:0.001265:0.002767:0.004500:0.002767:0.002655:0.001614:0.002886:0.002767:0.001303:0.001272:0.002767:0.001614:0.002830:0.001614:0.001303:0.002886:0.001272:0.001303:0.002886:0.002886:0.001272:0.001614:0.001272:0.002886:0.002537:0.002767:0.001845:0.001303:0.004500:0.002767:0.002886:0.001614:0.001303:0.001614:0.002767:0.001303:0.002767:0.004500:0.002767:0.002537:0.001303:0.001265:0.002537:0.002836:0.002767:0.001272:0.001614:0.002830:0.002655:0.001272:0.001272:0.002886:0.004500:0.002767:0.002655:0.001303:0.001272:0.003347:0.001303:0.001845:0.002767:0.002886:0.002886:0.003235:0.001303:0.001265:0.002076:0.002886:0.003465:0.001272:0.002998:0.002886:0.001303:0.001614:0.002767:0.001303:0.002886:0.002767:0.001272:0.001614:0.002830:0.002886:0.002886:0.001272:0.001614:0.002886:0.002767:0.002655:0.002537:0.001272:0.002886:0.001303:0.002886:0.002886:0.001272:0.002886:0.002886:0.001272:0.002530:0.002886:0.001272:0.001303:0.001265:0.002886:0.002767:0.002767:0.002767:0.001614:0.001303:0.002767:0.002886:0.001303:0.002886:0.001272:0.002886:0.002767:0.002886:0.002537:0.001303:0.002537:0.002767:0.001845:0.002886:0.002537:0.002767:0.002767:0.004500:0.001303:0.002767:0.001614:0.002830:0.001272:0.001845:0.002886:0.002767:0.001845:0.002886:0.002886:0.002830:0.001303:0.001265:0.001614:0.002886:0.002767:0.004500:0.001614:0.002830:0.002767:0.001845:0.001614:0.001303:0.002886:0.002886:0.001272:0.001845:0.002886:0.002886:0.001303:0.002767:0.001614:0.002830:0.001845:0.002767:0.001272:0.001845:0.002767:0.001614:0.002767:0.002886:0.001303:0.002493:0.001614:0.002886:0.002767:0.001272:0.001614:0.002830:0.002886:0.001303:0.002767:0.002537:0.002767:0.002886:0.001614:0.001303:0.001614:0.001272:0.001303:0.001265:0.002886:0.002767:0.001440:0.001440:0.001272:0.002537:0.002886:0.002767:0.001614:0.002886:0.001272:0.001303:0.002767:0.002886:0.001303:0.002886:0.001272:0.002886:0.002767:0.002886:0.002537:0.001303:0.002886:0.002767:0.001272:0.002537:0.001272:0.002530:0.001957:0.002767:0.002886:0.002886:0.002537:0.001303:0.002767:0.001614:0.002830:0.001272:0.001845:0.002886:0.002767:0.001845:0.002886:0.002886:0.002830:0.001303:0.002530:0.001272:0.001272:0.002767:0.002655:0.001272:0.002886:0.002767:0.004500:0.001303:0.001265:0.002886:0.002767:0.001272:0.001614:0.002655:0.002886:0.002886:0.001614:0.002537:0.002530:0.002948:0.001303:0.002655:0.002767:0.001272:0.002886:0.001845:0.002767:0.002655:0.001303:0.001845:0.002767:0.001303:0.002655:0.001272:0.001614:0.002830:0.002886:0.002767:0.002886:0.001303:0.001265:0.001272:0.002767:0.002886:0.002767:0.001845:0.001303:0.002886:0.001614:0.001272:0.004039:0.001303:0.002537:0.001614:0.002886:0.002767:0.001272:0.001614:0.002830:0.002886:0.001496
risk of gastrointestinal adverse effects when EXINEF is taken concomitantly with aspirin (even at low doses). Elevations of alanine aminotransferase (ALT) and/or aspartate aminotransferase (AST) (approximately 3 or more times the upper limit of normal) have been reported in approximately 1 % of patients in clinical trials treated for up to one year with EXINEF 60 and:@0.097940:0.900096:0.934619:0.900096:0.934619:0.893908:0.097940:0.893908:0.001845:0.001272:0.002537:0.002767:0.001352:0.002767:0.001614:0.001352:0.002886:0.002767:0.002537:0.001614:0.001845:0.002767:0.001272:0.002886:0.001614:0.002767:0.002537:0.001614:0.001272:0.002886:0.002767:0.001272:0.001352:0.002767:0.002886:0.002530:0.002767:0.001845:0.002537:0.002767:0.001352:0.002767:0.001614:0.001614:0.002767:0.002655:0.001614:0.002537:0.001352:0.004039:0.002886:0.002767:0.002886:0.001352:0.002886:0.002998:0.001272:0.003465:0.002886:0.002767:0.001352:0.001272:0.002537:0.001352:0.001614:0.002767:0.002767:0.002767:0.002886:0.001352:0.002655:0.002767:0.002886:0.002655:0.002767:0.004500:0.001272:0.001614:0.002767:0.002886:0.001614:0.001272:0.002530:0.001352:0.004039:0.001272:0.001614:0.002886:0.001352:0.002767:0.002537:0.002886:0.001272:0.001845:0.001272:0.002886:0.001352:0.001502:0.002767:0.002530:0.002767:0.002886:0.001352:0.002830:0.001614:0.001352:0.001272:0.002830:0.004039:0.001352:0.002886:0.002767:0.002537:0.002767:0.002537:0.001502:0.001265:0.001352:0.002886:0.001272:0.002767:0.002530:0.002830:0.001614:0.001272:0.002767:0.002886:0.002537:0.001352:0.002767:0.001614:0.001352:0.002767:0.001272:0.002767:0.002886:0.001272:0.002886:0.002767:0.001352:0.002767:0.004500:0.001272:0.002886:0.002767:0.001614:0.001845:0.002767:0.002886:0.002537:0.001614:0.002767:0.001845:0.002767:0.002537:0.002767:0.001352:0.001502:0.003116:0.002181:0.002886:0.001502:0.001352:0.002767:0.002886:0.002886:0.001733:0.002767:0.001845:0.001352:0.002767:0.002537:0.002886:0.002767:0.001845:0.001614:0.002830:0.001614:0.002767:0.001352:0.002767:0.004500:0.001272:0.002886:0.002767:0.001614:0.001845:0.002767:0.002886:0.002537:0.001614:0.002767:0.001845:0.002767:0.002537:0.002767:0.001352:0.001502:0.003116:0.003116:0.002886:0.001502:0.001352:0.001502:0.002830:0.002886:0.002886:0.001845:0.002767:0.002530:0.001272:0.004500:0.002830:0.001614:0.002767:0.001272:0.002530:0.001352:0.002992:0.001352:0.002767:0.001845:0.001352:0.004500:0.002767:0.001845:0.002767:0.001352:0.001614:0.001272:0.004500:0.002767:0.002537:0.001352:0.001614:0.002886:0.002767:0.001352:0.002886:0.002886:0.002886:0.002767:0.001845:0.001352:0.001272:0.001272:0.004500:0.001272:0.001614:0.001352:0.002767:0.001614:0.001352:0.002886:0.002767:0.001845:0.004500:0.002767:0.001272:0.001502:0.001352:0.002886:0.002830:0.002530:0.002767:0.001352:0.002886:0.002767:0.002767:0.002886:0.001352:0.001845:0.002767:0.002886:0.002767:0.001845:0.001614:0.002767:0.002886:0.001352:0.001272:0.002886:0.001352:0.002830:0.002886:0.002886:0.001845:0.002767:0.002530:0.001272:0.004500:0.002830:0.001614:0.002767:0.001272:0.002530:0.001352:0.002992:0.001352:0.004731:0.001352:0.002767:0.001614:0.001352:0.002886:0.002830:0.001614:0.001272:0.002767:0.002886:0.001614:0.002537:0.001352:0.001272:0.002886:0.001352:0.002530:0.001272:0.001272:0.002886:0.001272:0.002655:0.002767:0.001272:0.001352:0.001614:0.001845:0.001272:0.002767:0.001272:0.002537:0.001352:0.001614:0.001845:0.002767:0.002830:0.001614:0.002767:0.002886:0.001352:0.001614:0.002767:0.001845:0.001352:0.002886:0.002886:0.001352:0.001614:0.002767:0.001352:0.002767:0.002886:0.002767:0.001352:0.002530:0.002767:0.002767:0.001845:0.001352:0.004039:0.001272:0.001614:0.002886:0.001352:0.002886:0.002998:0.001272:0.003465:0.002886:0.002767:0.001352:0.002992:0.002992:0.001352:0.002767:0.002886:0.002886
 ciency or glucose-galactose malabsorption should not take EXINEF. The use of EXINEF is not recommended in fertile women attempting to conceive.ﬁ ammation or infection. EXINEF Tablets contain lactose. Patients with hereditary problems of galactose intolerance, the Lapp lactase deﬂ90 mg daily. EXINEF may mask fever and other signs of in :@0.097940:0.906451:0.892830:0.906451:0.892830:0.900263:0.097940:0.900263:0.001265:0.002767:0.002530:0.001272:0.002767:0.002655:0.002886:0.002767:0.002655:0.001652:0.002767:0.001614:0.001652:0.002886:0.002886:0.001272:0.001614:0.002886:0.004500:0.002767:0.001614:0.001614:0.002830:0.001652:0.002886:0.002767:0.004500:0.002767:0.004039:0.001652:0.002767:0.001272:0.001272:0.001614:0.001845:0.002767:0.001614:0.001652:0.002886:0.001272:0.001652:0.002886:0.002767:0.002886:0.002886:0.002767:0.004500:0.004500:0.002767:0.002655:0.002767:0.001845:0.001652:0.001614:0.002767:0.002886:0.001652:0.002537:0.001272:0.001652:0.002767:0.002886:0.003465:0.001272:0.002998:0.002886:0.001652:0.001614:0.002767:0.001652:0.002767:0.002537:0.002886:0.001652:0.002767:0.002886:0.002886:0.001421:0.001265:0.002076:0.002886:0.003465:0.001272:0.002973:0.002886:0.001652:0.002767:0.002767:0.002767:0.001614:0.001652:0.001614:0.002767:0.002886:0.001652:0.002886:0.001272:0.002886:0.002767:0.002886:0.002537:0.001652:0.002886:0.002767:0.001272:0.001614:0.002886:0.001845:0.002767:0.002537:0.002886:0.002767:0.001272:0.002767:0.004500:0.001652:0.002767:0.002537:0.002767:0.001614:0.002655:0.002767:0.001272:0.002767:0.002886:0.002194:0.002767:0.002537:0.002767:0.002655:0.002886:0.001272:0.002886:0.001652:0.001845:0.002767:0.001652:0.002530:0.002530:0.002886:0.002767:0.001272:0.002655:0.001440:0.001440:0.002767:0.002886:0.001652:0.002767:0.002537:0.002767:0.001614:0.002655:0.002767:0.001272:0.001652:0.002886:0.002886:0.002830:0.002767:0.001652:0.002767:0.002886:0.001614:0.001652:0.001265:0.002767:0.002655:0.002886:0.002767:0.001845:0.002767:0.001272:0.002767:0.001614:0.002886:0.001272:0.001652:0.002767:0.002537:0.002767:0.001614:0.002655:0.002767:0.001272:0.002767:0.002886:0.001652:0.001614:0.002767:0.001652:0.002537:0.004500:0.002767:0.001272:0.002886:0.002767:0.001845:0.002886:0.001652:0.002530:0.001957:0.002767:0.001614:0.001272:0.002886:0.002767:0.001845:0.002767:0.002886:0.001614:0.002886:0.001614:0.001272:0.004039:0.001652:0.002537:0.001614:0.002886:0.002767:0.001272:0.001614:0.002830:0.002886:0.001652:0.001265:0.002767:0.002537:0.002767:0.001614:0.002655:0.002767:0.001272:0.001652:0.002886:0.001272:0.002767:0.001614:0.002886:0.002767:0.002655:0.001652:0.002537:0.001614:0.002767:0.001272:0.002886:0.002767:0.002424:0.001421:0.002767:0.002886:0.003465:0.001272:0.002998:0.002886:0.001652:0.001265:0.002886:0.002767:0.001272:0.001614:0.002655:0.002767:0.001614:0.002886:0.001272:0.001652:0.001845:0.002767:0.001652:0.002886:0.002767:0.001272:0.001614:0.002830:0.004500:0.004500:0.002767:0.001440:0.001440:0.002886:0.001272:0.001652:0.001614:0.002767:0.001652:0.002537:0.002886:0.002886:0.001272:0.002537:0.001652:0.001845:0.002767:0.002886:0.001614:0.002767:0.001652:0.002886:0.002886:0.002767:0.001652:0.001845:0.002767:0.002530:0.002767:0.001614:0.001652:0.002767:0.002537:0.002767:0.004500:0.001652:0.002530:0.002767:0.004500:0.001652:0.002767:0.002886:0.003465:0.001272:0.002998:0.002886:0.001652:0.001265:0.002188:0.001272:0.001272:0.002767:0.002886:0.001652:0.002886:0.004500:0.001652:0.002992:0.002992:0.001496
SIDE EFFECTS: :@0.892954:0.906515:0.930356:0.906515:0.930356:0.900106:0.892954:0.900106:0.003235:0.001608:0.003578:0.002998:0.001652:0.002998:0.002886:0.002886:0.002998:0.003347:0.002992:0.003235:0.001496:0.001496
In :@0.930512:0.906451:0.936165:0.906451:0.936165:0.900263:0.930512:0.900263:0.001272:0.002886:0.001496
 atulence, heartburn), diarrhoea,ﬂ uid retention, dizziness, headache, palpitations, hypertension, gastrointestinal disorders (e.g. abdominal pain, ﬂ le was similar in patients with OA or RA treated with EXINEF for one year or longer. Very common (≥ 1/10) and Common (≥ 1/100, < 1/10) reported effects: alveolar osteitis, oedema/ﬁclinical studies, the undesirable effects pro :@0.097940:0.912806:0.936177:0.912806:0.936177:0.906618:0.097940:0.906618:0.001265:0.002767:0.002767:0.002767:0.002886:0.001845:0.001845:0.002767:0.001272:0.002886:0.001309:0.001265:0.001502:0.002886:0.001845:0.002886:0.002886:0.001614:0.001845:0.002767:0.002767:0.002886:0.001309:0.001265:0.002767:0.002655:0.002886:0.002767:0.001272:0.002886:0.001614:0.002830:0.001440:0.001440:0.001309:0.001265:0.002886:0.001272:0.002767:0.002886:0.001309:0.001272:0.002767:0.002886:0.001272:0.004500:0.002767:0.002886:0.002886:0.002767:0.001309:0.001265:0.002886:0.001496:0.002767:0.001502:0.001309:0.002537:0.001845:0.002767:0.002886:0.001845:0.002767:0.002537:0.001272:0.002886:0.001309:0.001272:0.002767:0.002886:0.001272:0.001614:0.002537:0.002767:0.001614:0.002886:0.001272:0.002767:0.001845:0.001614:0.002537:0.002767:0.002886:0.001309:0.001265:0.002886:0.002767:0.001272:0.002537:0.002886:0.002767:0.001614:0.001845:0.002767:0.002886:0.002530:0.002886:0.001309:0.001265:0.002537:0.002886:0.002767:0.001272:0.001614:0.002830:0.001614:0.001272:0.002886:0.001272:0.002767:0.002886:0.001309:0.001265:0.002767:0.002886:0.002655:0.002767:0.002886:0.002767:0.002767:0.002886:0.001309:0.001265:0.002537:0.002537:0.002767:0.002886:0.001272:0.002424:0.002424:0.001272:0.002886:0.001309:0.001265:0.002886:0.002767:0.001272:0.001614:0.002886:0.002767:0.001614:0.002767:0.001845:0.001309:0.002886:0.001272:0.002886:0.001440:0.001440:0.001733:0.002767:0.004500:0.002767:0.002886:0.002767:0.002767:0.001309:0.001265:0.002537:0.001272:0.001614:0.001272:0.002767:0.001614:0.002537:0.002767:0.001309:0.001845:0.002767:0.001272:0.002767:0.002767:0.002530:0.001272:0.002767:0.001309:0.001265:0.002537:0.001614:0.002655:0.002767:0.001614:0.001614:0.002767:0.001309:0.002886:0.002767:0.001614:0.001845:0.002767:0.002886:0.002767:0.001845:0.001309:0.001502:0.002992:0.002992:0.001733:0.002992:0.001309:0.003740:0.001309:0.001265:0.002992:0.002992:0.002992:0.001733:0.002992:0.001309:0.003098:0.001502:0.001309:0.002886:0.002767:0.004500:0.004500:0.002767:0.003235:0.001309:0.002886:0.002886:0.002767:0.001309:0.001502:0.002992:0.002992:0.001733:0.002992:0.001309:0.003098:0.001502:0.001309:0.002886:0.002767:0.004500:0.004500:0.002767:0.002655:0.001309:0.002530:0.001957:0.002767:0.002767:0.001078:0.001265:0.001384:0.002767:0.002886:0.002886:0.002767:0.001272:0.001309:0.001845:0.002767:0.001309:0.001845:0.002767:0.002767:0.002530:0.001309:0.002767:0.002886:0.002767:0.001309:0.001845:0.002767:0.001614:0.001309:0.002767:0.002886:0.003465:0.001272:0.002998:0.002886:0.001309:0.002886:0.001614:0.001272:0.004039:0.001309:0.002886:0.002767:0.001614:0.002830:0.002767:0.001845:0.001614:0.001309:0.003116:0.003235:0.001309:0.001845:0.002767:0.001309:0.003116:0.003465:0.001309:0.002886:0.001614:0.001272:0.004039:0.001309:0.002537:0.001614:0.002886:0.002767:0.001272:0.001614:0.002830:0.002886:0.001309:0.002886:0.001272:0.001309:0.001845:0.002767:0.001272:0.001272:0.004500:0.001272:0.002537:0.001309:0.002537:0.002767:0.004039:0.001309:0.002767:0.001272:0.001440:0.001440:0.002767:0.001845:0.002886:0.001309:0.002537:0.001614:0.002655:0.002767:0.001614:0.001614:0.002767:0.001309:0.002767:0.001272:0.002886:0.002767:0.001845:0.001272:0.002537:0.002767:0.002886:0.002886:0.002886:0.001309:0.002767:0.002886:0.001614:0.001309:0.001265:0.002537:0.002767:0.001272:0.002886:0.002886:0.001614:0.002537:0.001309:0.001272:0.002767:0.002655:0.001272:0.002886:0.001272:0.001272:0.002530:0.001496
 u-like disease, increased ALT, AST.ﬂdyspepsia, epigastric discomfort, nausea, ecchymosis, asthenia/fatigue, :@0.097940:0.919161:0.345791:0.919161:0.345791:0.912973:0.097940:0.912973:0.001496:0.002312:0.003116:0.003116:0.001265:0.001265:0.002312:0.002181:0.003116:0.001265:0.002886:0.002767:0.002537:0.002767:0.002767:0.001845:0.002655:0.002886:0.001272:0.001496:0.001265:0.002767:0.002537:0.002767:0.002767:0.002537:0.001272:0.002886:0.001496:0.002767:0.002767:0.001272:0.001272:0.002194:0.002886:0.001440:0.001440:0.001496:0.001265:0.002767:0.002886:0.002886:0.001272:0.001614:0.002830:0.001614:0.001733:0.002767:0.001272:0.002886:0.002767:0.002886:0.001614:0.002537:0.002767:0.001496:0.001265:0.002537:0.001272:0.002537:0.002767:0.004500:0.002530:0.002886:0.002655:0.002655:0.002767:0.001496:0.001265:0.002767:0.002767:0.002537:0.002886:0.002767:0.002886:0.001496:0.001265:0.001614:0.001845:0.002767:0.001614:0.004500:0.002767:0.002655:0.002537:0.001272:0.002886:0.001496:0.002655:0.001272:0.001845:0.001614:0.002537:0.002767:0.002886:0.001272:0.002886:0.002767:0.001496:0.001265:0.002767:0.001272:0.002537:0.002886:0.002767:0.002886:0.002537:0.002530:0.002948
REFERENCES: :@0.097940:0.808551:0.133952:0.808551:0.133952:0.802050:0.097940:0.802050:0.003578:0.003116:0.002998:0.003116:0.003578:0.003116:0.003690:0.003347:0.003116:0.003347:0.001390:0.001620
1:@0.133914:0.808518:0.136906:0.808518:0.136906:0.802109:0.133914:0.802109:0.002992
. Approved ARCOXIA package insert, October 2013.   . Approved EXINEF package insert, November 2014.   . Malmstrom K, Sapre A, Coughlin H,:@0.136906:0.808453:0.466703:0.808453:0.466703:0.802266:0.136906:0.802266:0.001265:0.001228:0.003179:0.002886:0.002886:0.001845:0.002767:0.002530:0.002767:0.002886:0.001228:0.003116:0.003235:0.003235:0.003316:0.002998:0.001272:0.003116:0.001458:0.002886:0.002767:0.002655:0.002767:0.002830:0.002886:0.002767:0.001458:0.001272:0.002886:0.002537:0.002767:0.001845:0.001614:0.001265:0.001458:0.003465:0.002655:0.001614:0.002767:0.002886:0.002767:0.001845:0.001458:0.002992:0.002992:0.002992:0.002992:0.001265:0.001458:0.001496:0.002954:0.001265:0.001228:0.003179:0.002886:0.002886:0.001845:0.002767:0.002530:0.002767:0.002886:0.001458:0.002886:0.002998:0.001272:0.003465:0.002886:0.002767:0.001458:0.002886:0.002767:0.002655:0.002767:0.002830:0.002886:0.002767:0.001458:0.001272:0.002886:0.002537:0.002767:0.001845:0.001614:0.001265:0.001458:0.003465:0.002767:0.002530:0.002767:0.004500:0.002886:0.002767:0.001845:0.001458:0.002992:0.002992:0.002992:0.002992:0.001265:0.001458:0.001496:0.002954:0.001265:0.001458:0.004388:0.002767:0.001272:0.004500:0.002537:0.001614:0.001845:0.002767:0.004500:0.001458:0.003116:0.001265:0.001458:0.003116:0.002830:0.002886:0.001845:0.002767:0.001228:0.003116:0.001265:0.001458:0.003235:0.002767:0.002886:0.002886:0.002886:0.001272:0.001272:0.002886:0.001458:0.003347:0.001496
2:@0.256384:0.808518:0.259376:0.808518:0.259376:0.802109:0.256384:0.802109:0.002992
3:@0.380599:0.808518:0.383591:0.808518:0.383591:0.802109:0.380599:0.802109:0.002992
 et al. :@0.466703:0.808778:0.480801:0.808778:0.480801:0.802266:0.466703:0.802266:0.001458:0.002767:0.001614:0.001458:0.002767:0.001272:0.001265:0.001496
Etoricoxib in acute pain associated with dental surgery: a randomized, double-blind, placebo- and active comparator-controlled dose-ranging study. :@0.480763:0.808453:0.820762:0.808453:0.820762:0.802266:0.480763:0.802266:0.002886:0.001614:0.002767:0.001845:0.001272:0.002655:0.002767:0.002530:0.001272:0.002886:0.001458:0.001272:0.002886:0.001458:0.002767:0.002655:0.002886:0.001614:0.002767:0.001458:0.002886:0.002767:0.001272:0.002886:0.001458:0.002767:0.002537:0.002537:0.002767:0.002655:0.001272:0.002830:0.001614:0.002767:0.002886:0.001458:0.004039:0.001272:0.001614:0.002886:0.001458:0.002886:0.002767:0.002886:0.001614:0.002767:0.001272:0.001458:0.002537:0.002886:0.001845:0.002886:0.002767:0.001957:0.002530:0.001265:0.001458:0.002767:0.001458:0.001845:0.002767:0.002886:0.002886:0.002767:0.004500:0.001272:0.002424:0.002767:0.002886:0.001265:0.001458:0.002886:0.002767:0.002886:0.002886:0.001272:0.002767:0.002194:0.002886:0.001272:0.001272:0.002886:0.002886:0.001265:0.001458:0.002886:0.001272:0.002767:0.002655:0.002767:0.002886:0.002767:0.002194:0.001458:0.002767:0.002886:0.002886:0.001458:0.002767:0.002655:0.001614:0.001272:0.002530:0.002767:0.001458:0.002655:0.002767:0.004500:0.002886:0.002767:0.001845:0.002830:0.001614:0.002767:0.001614:0.002194:0.002655:0.002767:0.002886:0.001614:0.001845:0.002767:0.001272:0.001272:0.002767:0.002886:0.001496:0.002886:0.002767:0.002537:0.002767:0.002194:0.001845:0.002767:0.002886:0.002886:0.001272:0.002886:0.002886:0.001458:0.002537:0.001614:0.002886:0.002948:0.002188:0.001265:0.001496
Clin Ther. :@0.820725:0.808778:0.843299:0.808778:0.843299:0.802266:0.820725:0.802266:0.003235:0.001272:0.001272:0.002886:0.001228:0.002886:0.002886:0.002767:0.001384:0.001265:0.001496
2004;26(5):667–679.   . Lin H-Y, Cheng :@0.843268:0.808453:0.936158:0.808453:0.936158:0.802266:0.843268:0.802266:0.002992:0.002992:0.002992:0.002992:0.001496:0.002992:0.002992:0.001502:0.002992:0.001502:0.001496:0.002992:0.002992:0.002992:0.003116:0.002992:0.002992:0.002992:0.001265:0.001458:0.001496:0.002954:0.001265:0.001458:0.002767:0.001272:0.002886:0.001458:0.003347:0.002194:0.002188:0.001265:0.001458:0.003235:0.002886:0.002767:0.002886:0.002886:0.001496
4:@0.895454:0.808518:0.898445:0.808518:0.898445:0.802109:0.895454:0.802109:0.002992
T-T, Wang J-H, :@0.097940:0.814808:0.132674:0.814808:0.132674:0.808621:0.097940:0.808621:0.002543:0.002194:0.002312:0.001265:0.001153:0.004388:0.002767:0.002886:0.002886:0.001384:0.002655:0.002194:0.003347:0.001265:0.001496
et al. :@0.132556:0.815133:0.145114:0.815133:0.145114:0.808621:0.132556:0.808621:0.002767:0.001614:0.001377:0.002767:0.001272:0.001265:0.001496
Etoricoxib improves pain, function and quality of life: results of a real-world effectiveness trial:@0.145002:0.814808:0.357869:0.814808:0.357869:0.808621:0.145002:0.808621:0.002886:0.001614:0.002767:0.001845:0.001272:0.002655:0.002767:0.002530:0.001272:0.002886:0.001377:0.001272:0.004500:0.002886:0.001845:0.002767:0.002530:0.002767:0.002537:0.001377:0.002886:0.002767:0.001272:0.002886:0.001265:0.001384:0.001614:0.002886:0.002886:0.002655:0.001614:0.001272:0.002767:0.002886:0.001377:0.002767:0.002886:0.002886:0.001384:0.002886:0.002886:0.002767:0.001272:0.001272:0.001614:0.002530:0.001377:0.002767:0.001614:0.001377:0.001272:0.001272:0.001614:0.002767:0.001265:0.001377:0.001845:0.002767:0.002537:0.002886:0.001272:0.001614:0.002537:0.001377:0.002767:0.001614:0.001377:0.002767:0.001377:0.001845:0.002767:0.002767:0.001272:0.002194:0.004039:0.002767:0.001845:0.001272:0.002886:0.001384:0.002767:0.001614:0.001614:0.002767:0.002655:0.001614:0.001272:0.002530:0.002767:0.002886:0.002767:0.002537:0.002537:0.001377:0.001614:0.001845:0.001272:0.002767:0.001272
. Int J Rheum Dis. :@0.357869:0.815133:0.399384:0.815133:0.399384:0.808621:0.357869:0.808621:0.001265:0.001377:0.001272:0.002886:0.001614:0.001377:0.002655:0.001384:0.003235:0.002886:0.002767:0.002886:0.004500:0.001377:0.003465:0.001272:0.002537:0.001265:0.001496
2010;13(2):144-150.   . Moore RA, Moore OA, Derry S, :@0.399272:0.814808:0.525912:0.814808:0.525912:0.808621:0.399272:0.808621:0.002992:0.002992:0.002992:0.002992:0.001496:0.002992:0.002992:0.001502:0.002992:0.001502:0.001496:0.002992:0.002992:0.002992:0.002194:0.002992:0.002992:0.002992:0.001265:0.001377:0.001496:0.002880:0.001265:0.001384:0.004388:0.002767:0.002767:0.001845:0.002767:0.001384:0.003235:0.003116:0.001265:0.001384:0.004388:0.002767:0.002767:0.001845:0.002767:0.001384:0.003465:0.003116:0.001265:0.001384:0.003465:0.002767:0.001845:0.001957:0.002530:0.001384:0.003116:0.001265:0.001496
5:@0.450379:0.814873:0.453371:0.814873:0.453371:0.808464:0.450379:0.808464:0.002992
et al. :@0.525806:0.815133:0.538371:0.815133:0.538371:0.808621:0.525806:0.808621:0.002767:0.001614:0.001384:0.002767:0.001272:0.001265:0.001496
Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice.:@0.538252:0.814808:0.934688:0.814808:0.934688:0.808621:0.538252:0.808621:0.003235:0.002767:0.002537:0.002886:0.002767:0.002886:0.002886:0.002767:0.001845:0.001384:0.002767:0.002886:0.002767:0.001272:0.002530:0.002537:0.001272:0.002537:0.001384:0.001614:0.002767:0.001845:0.001384:0.002886:0.002767:0.001272:0.002886:0.001384:0.001845:0.002767:0.001272:0.001272:0.002767:0.001614:0.001384:0.002767:0.002886:0.002886:0.001384:0.002886:0.002886:0.004500:0.002886:0.002767:0.001845:0.002537:0.001384:0.002886:0.002767:0.002767:0.002886:0.002767:0.002886:0.001384:0.001614:0.002767:0.001384:0.001614:0.001845:0.002767:0.002830:0.001614:0.001384:0.001272:0.002886:0.001384:0.002767:0.001384:0.004500:0.002767:0.001614:0.002767:0.002194:0.002767:0.002886:0.002767:0.001272:0.002530:0.002537:0.001272:0.002537:0.001384:0.002767:0.001614:0.001384:0.002767:0.001614:0.002767:0.001845:0.001272:0.002655:0.002767:0.002530:0.001272:0.002886:0.001384:0.002767:0.002537:0.001614:0.002767:0.002767:0.002767:0.001845:0.001614:0.002886:0.001845:0.001272:0.001614:0.001272:0.002537:0.001384:0.001614:0.001845:0.001272:0.002767:0.001272:0.002537:0.001265:0.001384:0.002886:0.001845:0.001272:0.002886:0.002886:0.001272:0.002886:0.002836:0.001384:0.002767:0.001384:0.002886:0.002830:0.002886:0.001384:0.002886:0.002767:0.001614:0.004039:0.002767:0.002767:0.002886:0.001384:0.002530:0.001272:0.001272:0.002886:0.001272:0.002655:0.002767:0.001272:0.001384:0.001614:0.001845:0.001272:0.002767:0.001272:0.002537:0.001384:0.002767:0.002886:0.002886:0.001384:0.002530:0.001272:0.001272:0.002886:0.001272:0.002655:0.002767:0.001272:0.001384:0.002886:0.001845:0.002767:0.002655:0.001614:0.001272:0.002655:0.002767:0.001496
Ann Rheum Dis. :@0.097940:0.821488:0.136526:0.821488:0.136526:0.814976:0.097940:0.814976:0.003116:0.002886:0.002886:0.001695:0.003235:0.002886:0.002767:0.002886:0.004500:0.001695:0.003465:0.001272:0.002537:0.001265:0.001496
2010;69:374-379.   . Nor Azlin MI, Maryasalwati I, Norzilawati MN, :@0.136725:0.821163:0.293973:0.821163:0.293973:0.814976:0.136725:0.814976:0.002992:0.002992:0.002992:0.002992:0.001496:0.002992:0.002992:0.001496:0.002992:0.002992:0.002992:0.002194:0.002992:0.002992:0.002992:0.001265:0.001695:0.001496:0.003191:0.001265:0.001695:0.003465:0.002767:0.001845:0.001465:0.003116:0.002424:0.001272:0.001272:0.002886:0.001695:0.004388:0.001272:0.001265:0.001695:0.004388:0.002767:0.001957:0.002593:0.002767:0.002537:0.002767:0.001334:0.004039:0.002830:0.001614:0.001272:0.001695:0.001272:0.001265:0.001695:0.003465:0.002767:0.001845:0.002424:0.001272:0.001272:0.002830:0.004039:0.002830:0.001614:0.001272:0.001695:0.004388:0.003465:0.001265:0.001496
6:@0.182466:0.821228:0.185458:0.821228:0.185458:0.814819:0.182466:0.814819:0.002992
et al. :@0.294172:0.821488:0.307049:0.821488:0.307049:0.814976:0.294172:0.814976:0.002767:0.001614:0.001695:0.002767:0.001272:0.001265:0.001496
The efficacy of etoricoxib vs mefenamic acid in the treatment of primary dysmenorrhoea: A randomised comparative trial.:@0.307248:0.821163:0.589565:0.821163:0.589565:0.814976:0.307248:0.814976:0.002886:0.002886:0.002767:0.001695:0.002767:0.001614:0.001614:0.001272:0.002655:0.002767:0.002530:0.002530:0.001695:0.002767:0.001614:0.001695:0.002767:0.001614:0.002767:0.001845:0.001272:0.002655:0.002767:0.002530:0.001272:0.002886:0.001695:0.002530:0.002537:0.001695:0.004500:0.002767:0.001614:0.002767:0.002886:0.002767:0.004500:0.001272:0.002655:0.001695:0.002767:0.002655:0.001272:0.002886:0.001695:0.001272:0.002886:0.001695:0.001614:0.002886:0.002767:0.001695:0.001614:0.001845:0.002767:0.002830:0.001614:0.004500:0.002767:0.002886:0.001614:0.001695:0.002767:0.001614:0.001695:0.002886:0.001845:0.001272:0.004500:0.002767:0.001957:0.002530:0.001695:0.002948:0.002530:0.002537:0.004500:0.002767:0.002886:0.002767:0.001845:0.001845:0.002886:0.002767:0.002767:0.002767:0.001265:0.001465:0.003116:0.001695:0.001845:0.002767:0.002886:0.002886:0.002767:0.004500:0.001272:0.002537:0.002767:0.002886:0.001695:0.002655:0.002767:0.004500:0.002886:0.002767:0.001845:0.002830:0.001614:0.001272:0.002530:0.002767:0.001695:0.001614:0.001845:0.001272:0.002767:0.001272:0.001496
 Journal of Obstetrics and Gynaecology. :@0.589565:0.821488:0.682885:0.821488:0.682885:0.814976:0.589565:0.814976:0.001695:0.002655:0.002767:0.002886:0.001845:0.002886:0.002767:0.001272:0.001695:0.002767:0.001614:0.001695:0.003465:0.002886:0.002537:0.001614:0.002767:0.001614:0.001845:0.001272:0.002655:0.002537:0.001695:0.002767:0.002886:0.002886:0.001695:0.003347:0.002530:0.002886:0.002767:0.002767:0.002655:0.002767:0.001272:0.002767:0.002948:0.002188:0.001265:0.001496
2008;28(4):424-426.   . Viscusi ER, Frenkl TL, Hartrick CT, :@0.683085:0.821163:0.819728:0.821163:0.819728:0.814976:0.683085:0.814976:0.002992:0.002992:0.002992:0.002992:0.001496:0.002992:0.002992:0.001502:0.002992:0.001502:0.001496:0.002992:0.002992:0.002992:0.002194:0.002992:0.002992:0.002992:0.001265:0.001695:0.001496:0.003191:0.001265:0.001465:0.002880:0.001272:0.002537:0.002655:0.002886:0.002537:0.001272:0.001695:0.002886:0.003235:0.001265:0.001695:0.002643:0.001845:0.002767:0.002886:0.002767:0.001272:0.001465:0.002886:0.002767:0.001265:0.001695:0.003347:0.002767:0.001845:0.001614:0.001845:0.001272:0.002655:0.002767:0.001695:0.003235:0.002312:0.001265:0.001496
7:@0.734821:0.821228:0.737813:0.821228:0.737813:0.814819:0.734821:0.814819:0.002992
et al. :@0.819927:0.821488:0.832804:0.821488:0.832804:0.814976:0.819927:0.814976:0.002767:0.001614:0.001695:0.002767:0.001272:0.001265:0.001496
Perioperative use of etoricoxib reduces pain :@0.833003:0.821163:0.936121:0.821163:0.936121:0.814976:0.833003:0.814976:0.002886:0.002767:0.001845:0.001272:0.002767:0.002886:0.002767:0.001845:0.002830:0.001614:0.001272:0.002530:0.002767:0.001695:0.002886:0.002537:0.002767:0.001695:0.002767:0.001614:0.001695:0.002767:0.001614:0.002767:0.001845:0.001272:0.002655:0.002767:0.002530:0.001272:0.002886:0.001695:0.001845:0.002767:0.002886:0.002886:0.002655:0.002767:0.002537:0.001695:0.002886:0.002767:0.001272:0.002886:0.001496
and opioid side-effects after total abdominal hysterectomy: a double-blind, randomized, placebo-controlled phase III study. :@0.097940:0.827518:0.381235:0.827518:0.381235:0.821331:0.097940:0.821331:0.002767:0.002886:0.002886:0.001546:0.002767:0.002886:0.001272:0.002767:0.001272:0.002886:0.001546:0.002537:0.001272:0.002886:0.002767:0.002194:0.002767:0.001614:0.001614:0.002767:0.002655:0.001614:0.002537:0.001546:0.002767:0.001614:0.001614:0.002767:0.001845:0.001546:0.001614:0.002767:0.001614:0.002767:0.001272:0.001546:0.002767:0.002886:0.002886:0.002767:0.004500:0.001272:0.002886:0.002767:0.001272:0.001546:0.002886:0.002530:0.002537:0.001614:0.002767:0.001845:0.002767:0.002655:0.001614:0.002767:0.004500:0.002530:0.001265:0.001546:0.002767:0.001546:0.002886:0.002767:0.002886:0.002886:0.001272:0.002767:0.002194:0.002886:0.001272:0.001272:0.002886:0.002886:0.001265:0.001546:0.001845:0.002767:0.002886:0.002886:0.002767:0.004500:0.001272:0.002424:0.002767:0.002886:0.001265:0.001546:0.002886:0.001272:0.002767:0.002655:0.002767:0.002886:0.002767:0.002194:0.002655:0.002767:0.002886:0.001614:0.001845:0.002767:0.001272:0.001272:0.002767:0.002886:0.001546:0.002886:0.002886:0.002767:0.002537:0.002767:0.001546:0.001272:0.001272:0.001272:0.001546:0.002537:0.001614:0.002886:0.002948:0.002188:0.001265:0.001496
Curr Med Res Opin. :@0.381278:0.827842:0.426716:0.827842:0.426716:0.821330:0.381278:0.821330:0.003180:0.002834:0.001805:0.001805:0.001510:0.004320:0.002717:0.002834:0.001510:0.003180:0.002717:0.002489:0.001510:0.003407:0.002834:0.001239:0.002834:0.001232:0.001479
2012;28(8):1323-1335.   . Bingham CO, Sebba AI, Rubin BR, :@0.426747:0.827517:0.565665:0.827517:0.565665:0.821330:0.426747:0.821330:0.002939:0.002939:0.002939:0.002939:0.001460:0.002939:0.002939:0.001467:0.002939:0.001467:0.001460:0.002939:0.002939:0.002939:0.002939:0.002150:0.002939:0.002939:0.002939:0.002939:0.001232:0.001510:0.001479:0.002964:0.001232:0.001510:0.003180:0.001239:0.002834:0.002834:0.002834:0.002717:0.004430:0.001510:0.003180:0.003407:0.001232:0.001510:0.003062:0.002717:0.002834:0.002834:0.002717:0.001282:0.003062:0.001239:0.001232:0.001510:0.003180:0.002834:0.002834:0.001239:0.002834:0.001510:0.003180:0.003180:0.001232:0.001479
8:@0.483091:0.827582:0.486048:0.827582:0.486048:0.821173:0.483091:0.821173:0.002958
et al.:@0.565690:0.827842:0.576929:0.827842:0.576929:0.821330:0.565690:0.821330:0.002717:0.001577:0.001510:0.002717:0.001239:0.001479
  cacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled,ﬁEf :@0.576911:0.827517:0.936198:0.827517:0.936198:0.821330:0.576911:0.821330:0.001510:0.001265:0.002886:0.002767:0.001272:0.001272:0.002767:0.001845:0.001614:0.002886:0.002767:0.002655:0.002194:0.002767:0.002886:0.002767:0.002655:0.002767:0.001272:0.002886:0.001546:0.001265:0.002886:0.002767:0.002424:0.001272:0.004500:0.002767:0.002886:0.002886:0.002767:0.001845:0.001546:0.001265:0.002886:0.002767:0.002886:0.002886:0.001272:0.002537:0.002767:0.002886:0.001546:0.002530:0.001272:0.001272:0.002767:0.002655:0.001272:0.001614:0.002886:0.002767:0.002886:0.001272:0.001546:0.002767:0.004039:0.001614:0.001546:0.002886:0.001272:0.001546:0.002537:0.001272:0.001614:0.001272:0.001845:0.002886:0.001614:0.001845:0.002767:0.002767:0.002767:0.001614:0.002537:0.002767:0.001546:0.001614:0.002767:0.001546:0.001614:0.002886:0.002767:0.004500:0.001614:0.002830:0.002767:0.001845:0.001614:0.001546:0.002767:0.002886:0.001614:0.001546:0.002886:0.001272:0.001546:0.002886:0.004500:0.001546:0.002992:0.002992:0.002992:0.001546:0.002886:0.001272:0.002530:0.002767:0.002655:0.002767:0.001272:0.002767:0.002655:0.001546:0.002886:0.002886:0.002767:0.001546:0.002825:0.004430:0.001510:0.002939:0.002939:0.001510:0.002834:0.001239:0.002483:0.002717:0.002607:0.001239:0.001805:0.002717:0.001577:0.002717:0.001510:0.001577:0.002717:0.001510:0.002483:0.001577:0.002717:0.001577:0.002717:0.002489:0.001510:0.002834:0.002834:0.002717:0.001510:0.002483:0.002483:0.002717:0.002607:0.001417:0.001417:0.001577:0.002834:0.001496
non-inferiority studies. :@0.097955:0.833872:0.150988:0.833872:0.150988:0.827685:0.097955:0.827685:0.002886:0.002767:0.002886:0.002194:0.001272:0.002886:0.001614:0.002767:0.001845:0.001272:0.002767:0.001845:0.001272:0.001614:0.002530:0.001359:0.002537:0.001614:0.002886:0.002886:0.001272:0.002767:0.002537:0.001265:0.001496
Rheumatology. :@0.150857:0.834197:0.186277:0.834197:0.186277:0.827685:0.150857:0.827685:0.003235:0.002886:0.002767:0.002886:0.004500:0.002830:0.001614:0.002767:0.001272:0.002767:0.002948:0.002188:0.001265:0.001496
2007;46:496–507.    Van der Heijde D, Baraf HSB, Ramos-Remus C, :@0.186146:0.833872:0.345394:0.833872:0.345394:0.827685:0.186146:0.827685:0.002992:0.002992:0.002992:0.002992:0.001496:0.002992:0.002992:0.001496:0.002992:0.002992:0.002992:0.003116:0.002992:0.002992:0.002992:0.001265:0.001365:0.001496:0.004357:0.001134:0.002767:0.002767:0.002886:0.001365:0.002886:0.002767:0.001845:0.001365:0.003347:0.002767:0.001272:0.001272:0.002886:0.002767:0.001365:0.003465:0.001265:0.001365:0.003235:0.002767:0.001845:0.002767:0.001614:0.001365:0.003347:0.003116:0.003235:0.001265:0.001365:0.003235:0.002767:0.004500:0.002767:0.002537:0.002194:0.003235:0.002767:0.004500:0.002886:0.002537:0.001365:0.003235:0.001265:0.001496
9.:@0.232148:0.833937:0.236636:0.833937:0.236636:0.827528:0.232148:0.827528:0.002992:0.001496
et al. :@0.345232:0.834197:0.357778:0.834197:0.357778:0.827685:0.345232:0.827685:0.002767:0.001614:0.001365:0.002767:0.001272:0.001265:0.001496
 cacy of Etoricoxib in Ankylosing Spondylitis.ﬁEvaluation of the Ef :@0.357648:0.833872:0.505366:0.833872:0.505366:0.827685:0.357648:0.827685:0.001265:0.002537:0.001272:0.001614:0.001272:0.001272:0.002530:0.002948:0.002886:0.002767:0.002886:0.003116:0.001365:0.002886:0.002886:0.001272:0.002537:0.002767:0.001272:0.002530:0.002767:0.002886:0.003116:0.001134:0.002886:0.001272:0.001365:0.002886:0.001272:0.002530:0.002767:0.002655:0.001272:0.001845:0.002767:0.001614:0.002886:0.001365:0.001614:0.002767:0.001365:0.002530:0.002530:0.002767:0.002655:0.001440:0.001440:0.001614:0.002886:0.001365:0.002767:0.002886:0.001614:0.001365:0.001614:0.002767:0.001365:0.002886:0.002767:0.001272:0.001614:0.002830:0.002886:0.001272:0.002767:0.002530:0.002886:0.001496
Arthritis & Rheumatism. :@0.505210:0.834197:0.561191:0.834197:0.561191:0.827685:0.505210:0.827685:0.003116:0.001845:0.001614:0.002886:0.001845:0.001272:0.001614:0.001272:0.002537:0.001365:0.003465:0.001365:0.003235:0.002886:0.002767:0.002886:0.004500:0.002830:0.001614:0.001272:0.002537:0.004500:0.001265:0.001496
2005;52(4):1205-1215.   . Daniels SE, Bandy DP, Christensen SE, :@0.561054:0.833872:0.715067:0.833872:0.715067:0.827685:0.561054:0.827685:0.002992:0.002992:0.002992:0.002992:0.001496:0.002992:0.002992:0.001502:0.002992:0.001502:0.001496:0.002992:0.002992:0.002992:0.002992:0.002194:0.002992:0.002992:0.002992:0.002992:0.001265:0.001365:0.001496:0.005852:0.001265:0.001365:0.003465:0.002767:0.002886:0.001272:0.002767:0.001272:0.002537:0.001365:0.003116:0.002886:0.001265:0.001365:0.003235:0.002767:0.002886:0.002948:0.002530:0.001365:0.003465:0.002194:0.001265:0.001365:0.003235:0.002886:0.001845:0.001272:0.002537:0.001614:0.002767:0.002886:0.002537:0.002767:0.002886:0.001365:0.003116:0.002886:0.001265:0.001496
10:@0.618113:0.833937:0.624096:0.833937:0.624096:0.827528:0.618113:0.827528:0.002992:0.002992
et al.:@0.714911:0.834197:0.726192:0.834197:0.726192:0.827685:0.714911:0.827685:0.002767:0.001614:0.001365:0.002767:0.001272:0.001496
 Evaluation of the Dose Range of Etoricoxib in an Acute Pain Setting Using the Postoperative :@0.726192:0.833872:0.936217:0.833872:0.936217:0.827685:0.726192:0.827685:0.001365:0.002886:0.002530:0.002767:0.001272:0.002886:0.002830:0.001614:0.001272:0.002767:0.002886:0.001365:0.002767:0.001614:0.001365:0.001614:0.002886:0.002767:0.001365:0.003465:0.002767:0.002537:0.002767:0.001365:0.003235:0.002767:0.002886:0.002886:0.002767:0.001365:0.002767:0.001614:0.001365:0.002886:0.001614:0.002767:0.001845:0.001272:0.002655:0.002767:0.002530:0.001272:0.002886:0.001365:0.001272:0.002886:0.001365:0.002767:0.002886:0.001134:0.003116:0.002655:0.002886:0.001614:0.002767:0.001365:0.002886:0.002767:0.001272:0.002886:0.001365:0.003116:0.002767:0.001614:0.001614:0.001272:0.002886:0.002886:0.001365:0.003235:0.002537:0.001272:0.002886:0.002886:0.001365:0.001614:0.002886:0.002767:0.001365:0.002886:0.002767:0.002537:0.001614:0.002767:0.002886:0.002767:0.001845:0.002830:0.001614:0.001272:0.002530:0.002767:0.001496
Dental Pain Model. :@0.097955:0.840227:0.142368:0.840227:0.142368:0.834040:0.097955:0.834040:0.003465:0.002767:0.002886:0.001614:0.002767:0.001272:0.001496:0.002886:0.002767:0.001272:0.002886:0.001496:0.004388:0.002767:0.002886:0.002767:0.001272:0.001265:0.001496
Clin J Pain. :@0.142368:0.840552:0.169249:0.840552:0.169249:0.834040:0.142368:0.834040:0.003235:0.001272:0.001272:0.002886:0.001496:0.002655:0.001496:0.002886:0.002767:0.001272:0.002886:0.001265:0.001496
2011;27(1):1–8.   . Matsumoto AK, Melian A, Mandel DR, :@0.169249:0.840227:0.304864:0.840227:0.304864:0.834040:0.169249:0.834040:0.002992:0.002992:0.002992:0.002992:0.001496:0.002992:0.002992:0.001502:0.002992:0.001502:0.001496:0.002992:0.003116:0.002992:0.001265:0.001496:0.001496:0.005983:0.001265:0.001496:0.004388:0.002830:0.001614:0.002537:0.002886:0.004500:0.002767:0.001614:0.002767:0.001265:0.003116:0.003116:0.001265:0.001496:0.004388:0.002767:0.001272:0.001272:0.002767:0.002886:0.001265:0.003116:0.001265:0.001496:0.004388:0.002767:0.002886:0.002886:0.002767:0.001272:0.001496:0.003465:0.003235:0.001265:0.001496
11:@0.209543:0.840292:0.215526:0.840292:0.215526:0.833883:0.209543:0.833883:0.002992:0.002992
et al. :@0.304864:0.840552:0.317541:0.840552:0.317541:0.834040:0.304864:0.834040:0.002767:0.001614:0.001496:0.002767:0.001272:0.001265:0.001496
for Etoricoxib Rheumatoid Arthritis Study Group. A randomised, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis.:@0.317541:0.840227:0.637029:0.840227:0.637029:0.834040:0.317541:0.834040:0.001614:0.002767:0.001845:0.001496:0.002886:0.001614:0.002767:0.001845:0.001272:0.002655:0.002767:0.002530:0.001272:0.002886:0.001496:0.003235:0.002886:0.002767:0.002886:0.004500:0.002823:0.001614:0.002767:0.001272:0.002886:0.001265:0.003116:0.001845:0.001614:0.002886:0.001845:0.001272:0.001614:0.001272:0.002537:0.001496:0.003116:0.001614:0.002886:0.002948:0.002530:0.001496:0.003347:0.001845:0.002767:0.002886:0.002886:0.001265:0.001265:0.003116:0.001496:0.001845:0.002767:0.002886:0.002886:0.002767:0.004500:0.001272:0.002537:0.002767:0.002886:0.001265:0.001496:0.002655:0.002767:0.002886:0.001614:0.001845:0.002767:0.001272:0.001272:0.002767:0.002886:0.001265:0.001496:0.002530:0.001272:0.001272:0.002886:0.001272:0.002655:0.002767:0.001272:0.001496:0.001614:0.001845:0.001272:0.002767:0.001272:0.001496:0.002767:0.001614:0.001496:0.002767:0.001614:0.002767:0.001845:0.001272:0.002655:0.002767:0.002530:0.001272:0.002886:0.001496:0.001272:0.002886:0.001496:0.001614:0.002886:0.002767:0.001496:0.001614:0.001845:0.002767:0.002830:0.001614:0.004500:0.002767:0.002886:0.001614:0.001496:0.002767:0.001614:0.001496:0.001845:0.002886:0.002767:0.002886:0.004500:0.002830:0.001614:0.002767:0.001272:0.002886:0.001496:0.002767:0.001845:0.001614:0.002886:0.001845:0.001272:0.001614:0.001272:0.002537:0.001496
 J Rheumatol. :@0.637029:0.840552:0.670192:0.840552:0.670192:0.834040:0.637029:0.834040:0.001496:0.002655:0.001496:0.003235:0.002886:0.002767:0.002886:0.004500:0.002830:0.001614:0.002767:0.001272:0.001265:0.001496
2002;29(8):1623–1630.:@0.670192:0.840227:0.725675:0.840227:0.725675:0.834040:0.670192:0.834040:0.002992:0.002992:0.002992:0.002992:0.001496:0.002992:0.002992:0.001502:0.002992:0.001502:0.001496:0.002992:0.002992:0.002992:0.002992:0.003116:0.002992:0.002992:0.002992:0.002992:0.001496
For full prescribing information refer to the package insert:@0.639108:0.938697:0.934691:0.938697:0.934691:0.927252:0.639108:0.927252:0.005856:0.006071:0.004212:0.003339:0.003744:0.006324:0.003035:0.003035:0.003339:0.006324:0.004212:0.005856:0.005615:0.005856:0.004212:0.003035:0.006324:0.003035:0.006324:0.006324:0.003339:0.003035:0.006324:0.003744:0.006071:0.004212:0.009587:0.006083:0.003744:0.003035:0.006071:0.006324:0.003339:0.004212:0.005856:0.003744:0.005856:0.004212:0.003339:0.003744:0.006071:0.003339:0.003744:0.006324:0.005856:0.003339:0.006324:0.006083:0.005856:0.006324:0.006083:0.006324:0.005856:0.003339:0.003035:0.006324:0.005615:0.005856:0.004212:0.003744
approved by the Medicines Regulatory Authority.:@0.689445:0.950769:0.935159:0.950769:0.935159:0.939324:0.689445:0.939324:0.006083:0.006324:0.006324:0.004212:0.006197:0.005615:0.005856:0.006324:0.003339:0.006324:0.005615:0.003339:0.003744:0.006324:0.005856:0.003339:0.009359:0.005856:0.006324:0.003035:0.005856:0.003035:0.006324:0.005856:0.005615:0.003339:0.007032:0.005856:0.006324:0.006324:0.003035:0.006083:0.003744:0.006071:0.004439:0.005615:0.003339:0.007032:0.006324:0.003744:0.006324:0.006071:0.004212:0.003035:0.003744:0.004920:0.003035
MSD (Pty) Ltd (Reg. No. 1996/003791/07),:@0.207705:0.939208:0.405308:0.939208:0.405308:0.928160:0.207705:0.928160:0.008904:0.006324:0.007032:0.003035:0.003048:0.006083:0.003276:0.005135:0.003048:0.003035:0.005615:0.003276:0.005856:0.003035:0.003048:0.006564:0.005615:0.005856:0.002567:0.003035:0.007032:0.005615:0.002567:0.003035:0.006071:0.006071:0.006071:0.006071:0.003516:0.006071:0.006071:0.006071:0.006071:0.006071:0.006071:0.003516:0.006071:0.006071:0.003048:0.003035
Private Bag 3, Halfway House, 1685. Tel: 011 655 3000. www.msd.co.za:@0.207705:0.951281:0.546074:0.951281:0.546074:0.940232:0.207705:0.940232:0.006083:0.003744:0.002580:0.005135:0.005742:0.003276:0.005615:0.003035:0.006564:0.005742:0.005856:0.003035:0.006071:0.002567:0.003035:0.006792:0.005615:0.002580:0.003276:0.008196:0.005615:0.005135:0.003035:0.006792:0.005615:0.005856:0.005148:0.005615:0.002567:0.003035:0.006071:0.006071:0.006071:0.006071:0.002567:0.002567:0.004920:0.005615:0.002580:0.002567:0.003035:0.006071:0.006071:0.006071:0.003035:0.006071:0.006071:0.006071:0.003035:0.006071:0.006071:0.006071:0.006071:0.002567:0.003035:0.008196:0.008196:0.007728:0.003035:0.009131:0.005148:0.005856:0.003035:0.005388:0.005615:0.003035:0.004920:0.005615
S3 :@0.099507:0.962735:0.110582:0.962735:0.110582:0.954724:0.099507:0.954724:0.004539:0.004357:0.002179
EXINEF:@0.114059:0.962819:0.139422:0.962819:0.139422:0.954521:0.114059:0.954521:0.004366:0.004875:0.002342:0.005211:0.004366:0.004203
 – Reg. No’s: 30 mg – 44/3.1/0898, 60 mg – 44/3.1/0899, 90 mg – 44/3.1/0900, 120 mg – 44/3.1/0901. Each EXINEF tablet contains 30 mg, 60 mg, 90 mg or 120 mg of etoricoxib.  S3 :@0.139422:0.962735:0.776838:0.962735:0.776838:0.954724:0.139422:0.954724:0.002515:0.004539:0.002515:0.004711:0.004031:0.004203:0.002179:0.002515:0.005047:0.004031:0.002179:0.003695:0.002179:0.002515:0.004357:0.004357:0.002515:0.006554:0.004203:0.002515:0.004539:0.002515:0.004357:0.004357:0.002524:0.004357:0.002179:0.004357:0.002524:0.004357:0.004357:0.004357:0.004357:0.002179:0.002515:0.004357:0.004357:0.002515:0.006554:0.004203:0.002515:0.004539:0.002515:0.004357:0.004357:0.002524:0.004357:0.002179:0.004357:0.002524:0.004357:0.004357:0.004357:0.004357:0.002179:0.002515:0.004357:0.004357:0.002515:0.006554:0.004203:0.002515:0.004539:0.002515:0.004357:0.004357:0.002524:0.004357:0.002179:0.004357:0.002524:0.004357:0.004357:0.004357:0.004357:0.002179:0.002515:0.004357:0.004357:0.004357:0.002515:0.006554:0.004203:0.002515:0.004539:0.002515:0.004357:0.004357:0.002524:0.004357:0.002179:0.004357:0.002524:0.004357:0.004357:0.004357:0.004357:0.002179:0.002515:0.004203:0.004031:0.003867:0.004203:0.002515:0.004203:0.004366:0.001852:0.005047:0.004203:0.004031:0.002515:0.002351:0.004031:0.004203:0.001852:0.004031:0.002351:0.002515:0.003867:0.004031:0.004203:0.002351:0.004031:0.001852:0.004203:0.003695:0.002560:0.004357:0.004357:0.002515:0.006554:0.004203:0.002179:0.002515:0.004357:0.004357:0.002515:0.006554:0.004203:0.002179:0.002515:0.004357:0.004357:0.002515:0.006554:0.004203:0.002515:0.004031:0.002687:0.002515:0.004357:0.004357:0.004357:0.002515:0.006554:0.004203:0.002515:0.004031:0.002351:0.002515:0.004031:0.002351:0.004031:0.002687:0.001852:0.003867:0.004031:0.003686:0.001852:0.004203:0.002179:0.002515:0.002515:0.004539:0.004357:0.002179
ARCOXIA:@0.779716:0.962819:0.811997:0.962819:0.811997:0.954521:0.779716:0.954521:0.005047:0.005047:0.004875:0.005047:0.004875:0.002342:0.005047
 – Reg. No’s: 30 mg – 44/3.1/0063, :@0.811997:0.962735:0.936844:0.962735:0.936844:0.954724:0.811997:0.954724:0.002515:0.004539:0.002515:0.004711:0.004031:0.004203:0.002179:0.002515:0.005047:0.004031:0.002179:0.003695:0.002179:0.002515:0.004357:0.004357:0.002515:0.006554:0.004203:0.002515:0.004539:0.002515:0.004357:0.004357:0.002524:0.004357:0.002179:0.004357:0.002524:0.004357:0.004357:0.004357:0.004357:0.002179:0.002179
60 mg – 37/3.1/0399, 90 mg – 37/3.1/0400, 120 mg – 37/3.1/0401. Each ARCOXIA tablet contains 30 mg, 60 mg, 90 mg or 120 mg of etoricoxib. Copyright © 2019 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ,:@0.099498:0.971424:0.935174:0.971424:0.935174:0.963414:0.099498:0.963414:0.004357:0.004357:0.002487:0.006554:0.004203:0.002487:0.004539:0.002487:0.004357:0.004357:0.002524:0.004357:0.002179:0.004357:0.002524:0.004357:0.004357:0.004357:0.004357:0.002179:0.002487:0.004357:0.004357:0.002487:0.006554:0.004203:0.002487:0.004539:0.002487:0.004357:0.004357:0.002524:0.004357:0.002179:0.004357:0.002524:0.004357:0.004357:0.004357:0.004357:0.002179:0.002487:0.004357:0.004357:0.004357:0.002487:0.006554:0.004203:0.002487:0.004539:0.002487:0.004357:0.004357:0.002524:0.004357:0.002179:0.004357:0.002524:0.004357:0.004357:0.004357:0.004357:0.002179:0.002487:0.004203:0.004031:0.003867:0.004203:0.002487:0.004539:0.004711:0.004711:0.005047:0.004366:0.001852:0.004539:0.002487:0.002351:0.004031:0.004203:0.001852:0.004031:0.002351:0.002487:0.003867:0.004031:0.004203:0.002351:0.004031:0.001852:0.004203:0.003695:0.002487:0.004357:0.004357:0.002487:0.006554:0.004203:0.002179:0.002487:0.004357:0.004357:0.002487:0.006554:0.004203:0.002179:0.002487:0.004357:0.004357:0.002487:0.006554:0.004203:0.002487:0.004031:0.002687:0.002487:0.004357:0.004357:0.004357:0.002487:0.006554:0.004203:0.002487:0.004031:0.002351:0.002487:0.004031:0.002351:0.004031:0.002687:0.001852:0.003867:0.004031:0.003686:0.001852:0.004203:0.002179:0.002487:0.004711:0.004031:0.004203:0.003686:0.002687:0.001852:0.004203:0.004203:0.002351:0.002487:0.007262:0.002487:0.004357:0.004357:0.004357:0.004357:0.002487:0.006391:0.004031:0.002687:0.003867:0.004031:0.002487:0.004539:0.004203:0.004031:0.002687:0.004203:0.002487:0.005047:0.002487:0.005047:0.004031:0.004203:0.006554:0.004031:0.002487:0.004711:0.004031:0.002687:0.004203:0.002179:0.001843:0.002487:0.004031:0.002487:0.003695:0.004203:0.004203:0.003695:0.001852:0.004203:0.001852:0.004031:0.002850:0.003686:0.002487:0.004031:0.002351:0.002487:0.006391:0.004031:0.002687:0.003867:0.004031:0.002487:0.005047:0.002487:0.004711:0.004031:0.002179:0.001843:0.002487:0.001852:0.004203:0.003867:0.002179:0.001843:0.002487:0.004539:0.004031:0.004203:0.001852:0.001943:0.005882:0.004031:0.002687:0.002351:0.004203:0.001843:0.002487:0.005047:0.003867:0.002179
USA. All rights reserved. ZA-CXB-00008 04/21:@0.099498:0.980114:0.255727:0.980114:0.255727:0.972104:0.099498:0.972104:0.004711:0.004539:0.004539:0.001843:0.002061:0.004539:0.001852:0.001852:0.002397:0.002687:0.001852:0.004203:0.004203:0.002351:0.003695:0.002397:0.002687:0.004031:0.003695:0.004031:0.002850:0.003686:0.004031:0.004203:0.001843:0.002397:0.004203:0.004539:0.003195:0.004711:0.004366:0.004711:0.003195:0.004357:0.004357:0.004357:0.004357:0.004357:0.002397:0.004357:0.004357:0.002524:0.004357:0.004357
   :@0.255727:0.980058:0.262699:0.980058:0.262699:0.972139:0.255727:0.972139:0.002397:0.002397:0.002179
EXINEF  30 Tablet is not marketed.:@0.816411:0.925096:0.935029:0.925096:0.935029:0.917085:0.816411:0.917085:0.004245:0.004410:0.001871:0.005098:0.004245:0.004071:0.004277:0.002201:0.004401:0.004401:0.001861:0.003567:0.004071:0.004245:0.001871:0.004071:0.002375:0.002201:0.001871:0.003732:0.002201:0.004245:0.004071:0.002375:0.002201:0.006620:0.004071:0.002714:0.004071:0.004071:0.002375:0.004071:0.004245:0.002201
®:@0.840352:0.922145:0.844628:0.922145:0.844628:0.917475:0.840352:0.917475:0.004277